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ABSTRACT

Boundary elements consisting of barriers and insulators are genomic sequence elements that
along with their associated DNA-binding proteins block the spread of heterochromatin into
euchromatic regions or prevent the targeted activation of promoters from distal/proximal
enhancers, respectively. In Saccharomyces cerevisiae, the deletion of RPD3, a histone
deacetylase, results in an extended SIR protein-mediated silencing effect bypassing a tRNAthr
barrier element adjacent to the cryptic mating locus, HMRa. We mutagenized rpd3∆ strains and
identified suppressor mutants through a genetic screen that no longer displayed this enhanced
silencing effect. Our results identified BRE1 and BRE2, which are either directly or indirectly
responsible for the tri-methylation of histone H3K4 and H3K79, as effectors of the rpd3Δ
extended silencing effect at HMRa. We hypothesize that the increased silencing effect in rpd3∆
mutants is the result of a redistribution of SIR proteins which become concentrated at the HMRa
region in response to a global change in the acetylation and/or methylation state of histones
contingent on RPD3, BRE1, and BRE2. ETC, or Extra-TFIIIC, sites are genomic elements which
bind the RNA Polymerase III transcription factor, TFIIIC. ETC sites contain B-box promoter
sequences normally associated with RNA Polymerase III promoters, and their locations are overrepresented between divergently transcribed RNA Polymerase II genes. Our results show that the
transcription of TFC6, which codes for a DNA-binding component of TFIIIC, is auto-regulated
by TFIIIC which binds to the ETC6 site in the TFC6 promoter region. Inhibition of TFIIIC binding
to the ETC6 site results in increased TFC6 expression from its own promoter, and transcription
of TFC6 is inversely correlated with TFIIIC binding to the ETC6 site. The TFC6 promoter is also
down-regulated when its own gene product is over-expressed. We present here a novel function
of gene regulation where a Pol III transcription factor directly (auto) regulates a Pol II gene. Our
viii

results also point to how this regulation might be mediated by an insulator-like function of TFIIIC
which can implicate the functionality of Extra-TFIIIC sites in other eukaryotes.
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CHAPTER ONE
INTRODUCTION
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Regulation of gene expression in eukaryotic cells involves a myriad of different genes
turned on or off and expressed in different temporal arrays. This is the hallmark in the control of
gene expression which dictates cellular responses to stimuli and cellular differentiation in
eukaryotic organisms. Different activating or repressive transcription factors are employed at
differing times to regulate the initiation or inhibition of transcription of different regions of
chromosomes in isogenic cells. Any disruption in cellular processes that result in the
misregulation of gene function and altered patterns of gene expression are key features of
abnormal cell proliferation or cancerous cells. Studies are consistently revealing that acquired
epigenetic abnormalities participate with genetic alterations to cause this misregulation. The
silencing of genes by DNA methylation and the alteration of the underlying chromatin
environment by histone modifications have led to the realization that genetics and epigenetics
cooperate at all stages of cell development. A primary factor in optimal cellular function is the
control of transcription, which is highly regulated so that genes are expressed only where and
when needed in the cell.
The transcription of DNA in eukaryotic cells occurs via the multi-subunit RNA polymerase
complexes which converts the DNA base sequence into an RNA strand with the same sequence
of one of the DNA strands (with uracil replacing thymine). The eukaryotic core RNA
polymerases have 12-20 different protein subunits and require many other accessory proteins for
proper transcription. The transcriptional initiation of a gene generally begins with the recruitment
of a preinitiation complex (PIC), which is positioned at or near the transcription start site of the
gene. Proteins known as general transcription factors combined with the RNA polymerase
complex constitute the PIC, the assembly of which is required to initiate transcription. The RNA
polymerase separates the two strands of DNA and positions a ribose nucleoside tri-phosphate
(rNTP) at the transcriptional start site. Once initiated, RNA polymerase can proceed to copy the
2

coding strand by polymerizing nucleotides 5’ to 3’ complementary to the template strand. RNA
polymerases form a “clamp” structure to bind to DNA. Since many eukaryotic genes are very
long, the polymerase must hold on tightly to have the high processivity required to make it to the
end of the gene. Inside the RNA polymerase complex is a “transcription bubble” of about eight
nucleotides where the newly synthesized RNA is base paired with the DNA template strand near
the active site. This base pairing is critical to maintaining the integrity of the
DNA:RNA:polymerase complex. Specific regulatory sequences within the DNA mark the start
and the ends of the regions to be transcribed and determine which strand of DNA is used as the
template for RNA synthesis. RNA polymerase does not require a primer to initiate synthesis, but
is directed to the proper site on DNA by nearby cis-acting sequences called promoters.
Most genes have additional transcription factor binding sites at regions from less than a
hundred to several thousands of base pairs from the promoter. These sequences are called
enhancers, as they stimulate the frequency of transcription initiation from a promoter. Enhancers
can be located upstream of genes, within introns, and even downstream of the gene. Enhancer
function is typically orientation and distance independent unlike proximal promoters. Much of
our direct knowledge of how enhancers might activate transcription comes from studies of yeast
Upstream Activation Sequences (UAS), the yeast counterpart of metazoan enhancers (Farrell,
Simkovich et al. 1996). Current evidence suggests that UAS-bound proteins interact with
components of the transcription complex to increase the probability that the PIC will find (have a
stable interaction with) the promoter. Current theories suggest that DNA is looped out to
accommodate enhancer-promoter interactions. Another proposed mechanism for enhancer
activity has included the targeting of chromatin-modifying enzymes to the promoter region, thus
making the promoter more accessible to the transcription machinery.
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The regulation of transcription involves the utilization of transcriptional activators or
repressors which can increase or decrease the rate of transcription of its target gene.
Transcriptional activators such as Gal4, one of the first characterized transcription factors in
yeast, have multiple domains that can fold and function independently. These proteins typically
contain N-terminal DNA binding domains of various types along with a nuclear localization
signal for import into the nucleus (Figure 1.1).

Figure 1.1. Generic transcription factor bound to sequence element. Transcriptional
activators bind to sequence elements (e.g. promoters, enhancers or UAS in yeast) located either
upstream or downstream of the +1 site. They are typically polypeptide monomers that dimerize
and bind to sequence palindromes in the genome, but different transcription factors can also form
heterodimers. These monomers typically contain an N-terminal DNA-binding domain (BD) that
also contains a nuclear localization signal, a dimerization domain (hatched domain between AD
and BD), and a C-terminal activation domain (AD) rich in acidic amino acids.
Examples of DNA-binding domains include zinc modules, homeodomains, and bZIP or bHLH.
There is also a domain for the dimerization of two independent monomers that are followed with
activation domains which are rich in acidic amino acids near the C-terminal end. These
activating regions can also consist of glutamine rich or proline rich domains. These transcription
factors are brought in proximity to promoters where they function to activate or repress
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holoenzyme recruitment. Unlike prokaryotes which utilize a single RNA polymerase to
transcribe their whole genome, eukaryotic cells contain three distinct RNA polymerases which
partially overlap in subunit composition and are recruited by different general transcription factor
complexes to transcribe different types of RNA molecules. RNA Polymerase I (Pol I), which is
primarily located in the nucleolus, transcribes the larger RNA responsible for the main structural
and catalytic center of the ribosome (rRNA) (Paule and White 2000).

Weaver, R.F. Molecular Biology, 3rd Ed. 2005.
Figure 1.2. Generic RNA polymerase I promoter. The RNA polymerase I gene promoter
elements consists of the UPE or upstream promoter element in gold and the “core” region in blue
containing the transcriptional start site or +1 site.
The RNA Pol I promoter region consists of a “core” region bound by a complex of proteins
called SL1 (Figure 1.2). This complex is essential to recruit Pol I to rRNA genes. The SL1
complex contains TBP and three TAFIs (110, 63, and 48). The UPE or upstream promoter region
is bound by a single polypeptide, named UBF (UPE-binding factor) in human cells, or UAF
(upstream activation factor) in yeast. In vitro transcription of rDNA genes by Pol I requires both
UBF and SL1 (Paule and White 2000).
RNA Polymerase II (Pol II), found throughout the nucleoplasm, transcribes the
heterogeneous nuclear RNA (hnRNA). This hnRNA consists of mostly protein coding mRNAs,
along with most small nuclear spliceosomal RNA. The Pol II complex contains 12 protein
subunits, and the largest subunit (RPB1) has an unusual carboxy terminal domain (CTD) with
nearly perfect repeats of the amino acids YSPTSPS (27 in yeast, 52 in human), and the functions

of the CTD are highly regulated by phosphorylation on these residues. The IIA form of Pol II has
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an unphosphorylated CTD and is the initiating form of the complex. The IIO form of Pol II is the
elongating form, which is phosphorylated on its CTD. The CTD, which is essential for viability
in yeast, also binds to components of chromatin remodeling complexes, and is involved in the
splicing, termination, capping and polyadenylation of mRNAs. Besides RNA polymerase II,
other factors are recruited to the promoter including the general transcription factors TFIIA,
TFIIB, TFIID, TFIIE, TFIIF, TFIIH, a mediator complex, and the TATA-binding protein (TBP)
which is associated with TFIID. Generic Pol II promoters contain an initiator region around the
+1 or CAP site, a TATA box, a TFIIB recognition element, and upstream and downstream
promoter elements (Figure 1.3).

Weaver, R.F. Molecular Biology, 3rd Ed. 2005.
Figure 1.3. Generic RNA polymerase II promoter. The upstream element in gold binds an
activating transcription factor. BRE in purple is the TFIIB, a non-sequence specific general
transcription factor, recognition element. The TATA box in red is an AT rich sequence about 25
bases upstream of the CAP site and binds the TBP or TATA-binding protein. The initiator (Inr)
in green is centered around the CAP site. The DPE or downstream promoter element is located
downstream from the CAP site.
The ordered assembly on Pol II genes is TFIID (which is also associated with numerous TAFIIs
or TBP-associated factors), TFIIB, Pol II which requires the presence of TFIIH, then the other
factors. TFIIB links TBP with the polymerase, TFIIA imparts directionality to the preinitiation
complex; TFIIH functions as a helicase to unwind the strands of DNA allowing the
polymerization of nucleotides complementary to the template strand and is stimulated by TFIIE
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(Hahn 2004).TFIIF is hypothesized to direct the polymerase to preformed TFIID:TFIIA:TFIIB
complexes. There are other Pol II promoter regions such as GC boxes which can bind the
transcription factor SP1 and CCAAT boxes which binds CTF (CCAAT binding factor) or CEBP
(CCAAT/Enhancer binding protein) (Hahn 2004).
RNA Polymerase III (Pol III) mainly transcribes the transfer RNA (tRNA) molecules that
read the information encoded in the mRNA and translates it into protein sequence, but also
transcribes the 5S ribosomal RNA, RNase P (RPR1), the U6 small nuclear spliceosomal RNA
(SNR6), the cytoplasmic RNA of the signal recognition particle (SCR1), and Alu repeats (Paule
and White 2000; Geiduschek and Kassavetis 2001; Huang and Maraia 2001). There are three
types of RNA Polymerase III (Pol III) promoters which are grouped according to the
organization of the binding sites for the core transcription factors TFIIIB and TFIIIC (Figure 1.4).
Type 1 consists of the 5S ribosomal gene and contains an intragenic promoter region ICR (or
Internal Control Region) which consists of a Box A and Box C sequence flanking an intergenic
element (IE).
Transcription of the 5S gene requires the additional gene-specific factor TFIIIA. In yeast, 5S
RNA genes are arranged in tandem with the 35S RNA genes where there are arrays of 100-200
copies of these genes. In contrast, the 274 tRNA genes with Type II promoters are distributed
throughout the genome (Percudani, Pavesi et al. 1997; Hani and Feldmann 1998). The Type II
promoter consists of intragenic A and B box elements, and includes all tRNA genes. The Type
III promoter is a hybrid consisting of Box A and B elements and a TATA sequence in yeast.
Human Type III promoters contain no Box A or Box B elements, but do contain TATA and
downstream and upstream promoter elements.
The focus of this dissertation is principally on the Type II mechanism involved in tRNA
transcription where both the presence of the Pol III complex and the transcription potential of the
7

tRNA gene can function as a chromatin boundary; and the Box B promoter sequence potentially
functions as an insulator element.

Adapted from Schramm and Hernandez, (2002)
Figure 1.4. Different types of RNA polymerase III promoters. Type 1 promoter (5S) contains
intragenic A and C boxes flanking an intergenic element (IE). All three elements of the Type I
promoter are referred to as the Internal Control Region (ICR). Type 2 promoter (tRNA) contains
an A and B box. Type 3 promoter (Hs U6) contains a Distal Sequence Element (DSE), a
Proximal Sequence Element (PSE), and a TATA box all located upstream of the transcription
start site (TSS) similar to RNA Polymerase II genes. The Saccharomyces U6 gene contains an
intragenic A box, a TSS upstream TATA box, and a B box located surprisingly downstream of
the transcription termination sequence (TTTT). Each promoter type above contains a plus
number above the transcription termination sequence (TTTT) indicating the length of the gene in
base pairs.
In tRNA gene (Type II) transcription initiation, the Pol III specific transcription factor TFIIIC is
recruited to the two intragenic sequences Box A and Box B downstream of the transcription start
8

site and remains tethered to these highly conserved regions of DNA (Figure 1.5). Next, TFIIIC
recruits the Pol III transcription factor TFIIIB that contains the TATA-binding protein (TBP)
subunit, and is essential for transcription initiation.

Robert Weaver, 4th ed., (2008)
Figure 1.5. RNA polymerase III Type II (tRNA) transcription initiation. The transcription
factor complex TFIIIC, through its DNA binding subunits, binds to Box A and Box B sequences
within the coding region of the tRNA gene. TFIIIC recruits the transcription factor TFIIIB which
contains TATA-binding protein (TBP) that participates in TFIIIB stability. TFIIIB then recruits
RNA polymerase III where processive transcription can now occur. Reinitiation of transcription
may or may not require the TFIIIC complex.
TFIIIC thus indirectly influences start site selection (Bartholomew, Meares et al. 1990). Bound
TFIIIB then recruits and correctly positions RNA Polymerase III at the transcription start site
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where transcription of the tRNA gene is initiated. TFIIIB-DNA complexes are competent to direct
initiation and multiple rounds of transcription after TFIIIC complexes are stripped (Kassavetis,
Braun et al. 1990). Mechanistically, TFIIIC bound at the Box A and Box B promoter elements
opens the DNA duplex for the advancing Pol III (Bardeleben, Kassavetis et al. 1994).
Gene expression in eukaryotes is not simply regulated by the direct binding of repressors
and activators to promoter elements along with the recruitment of a preinitiation complex, but
also by the structure of the chromatin in which the given gene resides. Eukaryotic DNA is
packaged and highly condensed in the nucleus through its association with histone proteins and
additional non-histone chromatin associated proteins. Chromatin typically exists as two distinct
states: euchromatin and heterochromatin (Figure 1.6).

Figure 1.6. Types of chromatin. Euchromatin (green nucleosomes), early replicating,
transcriptionally active, hyperacetylated histone tails, less condensed structure; Heterochromatin
(red nucleosomes), late replicating, transcriptionally repressed, hypoacetylated histone tails,
more condensed structure with the binding of heterochromatin-associated proteins.
Heterochromatin-associated proteins (e.g. Sir complex) are in yellow.
Euchromatin is the term that is associated with regions of the nucleoprotein complexes that are
transcriptionally active, early replicating, and generally have hyperacetylated N-terminal histone
10

tails. Heterochromatin refers to a more condensed structure that is minimally transcribed, late
replicating, and generally associated with hypoacetylated histone tails (Weiler and Wakimoto
1995).
The maintenance of the silent and/or open state has been shown to be heritably stable for ten
generations or more (Pillus and Rine 1989). These two states of chromatin are not necessarily
static since the chromatin environment of the underlying DNA can change between the open and
closed states depending on changes in histone modifications, the binding of chromatin-associated
proteins, or the activity of different signaling proteins in the cell. Heterochromatic gene silencing
differs from simple repression in that larger regions of chromosomes, not just individual
promoters, are repressed. Not only is the transcriptional potential of any gene dependent on the
underlying chromatin environment, but all aspects of eukaryotic DNA function (transcription,
replication, recombination, repair) must occur within the context of chromatin where the
nucleosome, a nucleoprotein complex, is the fundamental unit.
The nucleosome consists of an octamer of four core histone proteins H3, H4, H2A, and
H2B (two of each) around which approximately 147 bp of DNA are wrapped, and also contains
~20-60 bp of linker DNA which connects adjacent nucleosomes (~ 20 bp in S. cerevisiae, ~40-50
in humans). These proteins are abundant and comprise ~50% of total nuclear protein. The core
histones (H2A, H2B, H3, and H4) are small, positively charged (basic) proteins (20-25% lysine
and arginine) that share a conserved domain which folds into a conserved structure, the histone
fold domain. This protein structure is composed of three α-helices separated by two short loops.
The structure mediates the formation of head to tail dimers of specific pairs of histones (H2A +
H2B, H3 + H4), which mediates the assembly of the nucleosome core particle on DNA.
Nucleosomes are extremely stable protein-DNA complexes under physiological conditions
because of 14 contact points that occur between the histone core and the DNA duplex, with >120
11

direct atomic interactions (Luger, Mader et al. 1997). The numerous contact points are wellsuited for the packing function that is required for chromatin, especially during mitosis. In higher
eukaryotes, a histone H1 linker protein binds to linker DNA that adjoins two adjacent
nucleosomes and participates heavily in chromatin remodeling through phosphorylation of H1
during the condensation of chromosomes during mitosis (Allan, Cowling et al. 1981).
The histone proteins are mainly globular but have N-terminal tails that extend out from the
nucleosome core and are also partly responsible for the compaction of chromatin, but are subject
to different covalent modifications (e.g. acetylation, methylation, and phosphorylation) at
specific residues. The specific pattern of histone modifications can determine whether
transcriptional activators or RNA polymerase can bind to and/or function on the underlying
DNA.
There are over 60 different residues on histones where modifications have been detected
either by specific antibody binding or by mass spectrometry (Figure 1.7). Extra complexity
comes from the fact that methylation at lysines or arginines may be one of three forms: mono-,
di-, or trimethyl for lysines and mono- or di- (asymmetric or symmetric) for arginines. These
modifications have been shown to recruit other histone modification enzymes and/or chromatin
remodeling factors (Luger, Mader et al. 1997; Lorch, Zhang et al. 1999; Wu and Grunstein
2000). It has been shown that the N-terminal tails of histone H4 play a vital role in establishing a
heterochromatin environment, since deletion of the N-terminal tails abolished the establishment
of heterochromatin (Kayne, Kim et al. 1988). The covalent modifications that occur on the Nterminal tails of histone proteins are hypothesized to represent a “histone code” indicating the
expression state of the underlying chromatin (Strahl and Allis 2000; Turner 2000; Jenuwein and
Allis 2001). Effector proteins translate this code by binding to specific modifications on the
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histones. The binding of these effector proteins then can lead to further chromatin modifications
which can ultimately dictate particular expression states of the underlying chromatin.

Figure 1.7. Summary of the most common post-translational histone modifications on the
N-terminal histone tails and inside the nucleosome core. Depicted above is a schematic of the
amino terminal tails of histones H3, H4, H2A, and H2B (only one each shown for clarity)
extending out from the nucleosomal core. The N-terminal tails are subjected to different posttranslational modifications depending on the specific amino acid residue and position. Shown
above are the amino acids, K (Lysine), R (Arginine), S (Serine) with their numbered position
along with the modification. Me is methylation (Red), Ac is acetylation (Light Blue), P is
phosphorylation (Purple), and Ub is Ubiquitylation (Gold).
Histone modifications are also known to reinforce or inhibit one another, with one modification
affecting the likelihood of other modifications. The acetylation of lysine residues, the
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methylation of lysine and arginine residues, the phosphorylation of serine residues, and
ubiquitylation of lysine residues on histone proteins have all been implicated in the activation of
transcription; whereas certain residues of histone proteins with modifications of methylation,
ubiquitylation, sumoylation, deamination, and proline isomerization have been implicated in
transcriptional repression.
Histone proteins H3 and H4 that have acetylated lysine residues typically have roles in
transcriptional activation and sometimes even in repression (Fisher-Adams and Grunstein 1995;
Megee, Morgan et al. 1995); whereas the N-terminal tails of H3 and H4 are hypoacetylated in
silenced heterochromatin (Braunstein, Rose et al. 1993; Suka, Suka et al. 2001). The acetylation
state of the histone tails is believed to determine DNA-histone compaction by virtue of the
interacting charges between the modified amino acid and the DNA backbone. The DNA
backbone is negatively charged and wrapped around a positively charged histone core. The
acetylation of lysine residues seems to partially relieve DNA-histone compaction by neutralizing
the lysine residue’s positive charge.
Three distinct classes of histone deacetylases (HDAC) have been discovered: class I, II, and
the class III NAD+-dependent enzymes of the SIR (Silent Information Regulator) family. The
histone deacetylase, Sir2p, preferentially deacetylates H4K16 in vitro and is essential in
establishing in vivo silencing in S. cerevisiae (Imai, Armstrong et al. 2000; Meijsing and
Ehrenhofer-Murray 2001; Tanny and Moazed 2001; Suka, Luo et al. 2002). In general, HDACs
do not have preference for a particular acetyl group but some, like Sir2p, do have specificity for
a particular histone such as Hda1p for H3 and H2B, and Hos2p for H3 and H4 (Vaquero, Scher
et al. 2006).
Lysine methyltransferases have enormous specificity compared to acetyltransferases as they
usually modify only one lysine residue on a single histone and can either be activating or
14

repressive to transcription (Bannister and Kouzarides 2005). The methylation of lysine 4 on H3
appears to be a euchromatic imprint in a wide range of organisms (Strahl, Ohba et al. 1999). In
other higher eukaryotes, including Schizosaccharomyces pombe (S. pombe), methylation of
lysine 9 on H3 (H3K9) and lysine 27 on H3 (H3K27) are characteristic methylation marks in
heterochromatic regions. These heterochromatic regions include the presence of the
chromodomain-containing Heterochromatin Protein 1 (HP1) and a significant lack of acetylation
marks. HP1 mediates the recruitment of additional chromodomain-containing Histone Methyl
Transferase (HMT) activity to establish heterochromatic states in higher eukaryotes. There are
only three known histone H3 methylation sites in yeast – H3K4, H3K36, and H3K79 and each
has a specific distribution pattern. Dot1p is a lysine methyltransferase in yeast specific for
H3K79 which is unexpectedly located in the nucleosome core (Feng, Wang et al. 2002; van
Leeuwen, Gafken et al. 2002). The methylation of lysine 79 of histone H3 is thought to prevent
the binding of Sir proteins (van Leeuwen, Gafken et al. 2002). The methylation of histone H3
lysine 4 (H3K4) in S. cerevisiae is mediated by Set1p (Briggs, Bryk et al. 2001).
The influence of the histone code is expanding in relation to the methylation state of both
lysine and arginine residues. Since methylation of lysine residues can also occur as a mono-, dior tri-methylation on a single lysine residue, new evidence is beginning to show a differential but
gradual distribution of di- and tri-methylation patterns between promoter regions and open
reading frames (Cuthbert, Daujat et al. 2004; Carrozza, Li et al. 2005; Joshi and Struhl 2005;
Keogh, Kurdistani et al. 2005). This significantly adds to the complexity of the underlying
histone code in determining open or closed chromatin states. Currently, there is only one known
H3K4me3 demethylase in budding yeast, JhD2p (Liang, Klose et al. 2007). Due to limiting
histone lysine demethylases, the methylation of lysine residues seems to represent a more longterm epigenetic mark for maintaining chromatin states, as DNA replication and semiconservative
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nucleosome distribution appears to be the sole means to “dilute” histone lysine methylation
below a critical threshold level.
The phosphorylation of serine residues by specific kinases on N-terminal histone tails is
most prominent during cell division. This modification is spatially and temporally correlated
with mitotic and meiotic chromatin condensation (Wei, Mizzen et al. 1998). Many protein
phosphorylation cascades may have a more direct effect on gene expression through the
phosphorylation of chromatin at serine residues. Snf1p, a kinase in budding yeast has been
shown to target H3S10.
The relatively large modification of ubiquitylation on lysine residues can be found mainly
on the histone proteins H2A and H2B. The modification of H2BK123 in yeast is mediated by
Rad6/Bre1, an E2 ubiquitin-conjugating/E3 ubiquitin-ligase, and is required for the subsequent
trimethylation of H3K4 and H3K79 which is associated with transcriptional activation (Zhu,
Zheng et al. 2005). The chromatin-modifying functions of ubiquitylation are somewhat unclear.
It more than likely recruits additional chromatin factors, but may also function to physically keep
chromatin open by a “wedging” process, given its large size.
The genomes of multi-cellular organisms consist of different hypothetically demarcated
regions of gene expression based on whether or not the underlying DNA is in an open or closed
conformation. The demarcation line between these differing regions of expression can occur on
sequence elements between regions of differing chromatin states, resulting in position effect
silencing of adjacent genes and/or blocked transcriptional activation of nearby gene promoters.
These sequence elements along with their associated DNA-binding proteins are known as
boundary elements and are functionally characterized as either barriers that block the spread of
heterochromatic silencing into regions of open and transcriptionally active genes, or as insulators
that block the transcriptional activation of genes by enhancers from distal (or even proximal)
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genomic regions (Figure 1.8). Enhancer blocking only occurs if the insulator is situated between
the enhancer and promoter, not if it is placed elsewhere.

Figure 1.8. Two types of boundary elements: barriers and insulators. Barriers are sequences
within the genome and their associated DNA-binding proteins (green oval) that block the spread
of heterochromatin (yellow/red) into euchromatic regions (green/orange). Insulators are
sequence elements along with their DNA-binding proteins that block the promiscuous
transcriptional activation of gene promoters from distal and proximal enhancers.
Most studies on enhancer-blocking deal primarily with protein-protein interactions that may
interfere with the activity of complexes mediating normal enhancer-promoter communication.
Compound elements are sequence elements that contain closely-spaced enhancers and enhancerblockers that are typically polar in nature (West, Gaszner et al. 2002). Some blocking elements
(insulators) do appear to show polarity function in an orientation-dependent manner, unlike
enhancers which are typically both orientation- and distance-independent (Hark, Schoenherr et
al. 2000; Bell, West et al. 2001). A wide variety of enhancer-blocking elements have been
identified (mainly in Drosophila) and an increasing number are being found in vertebrates
(Kellum and Schedl 1991).
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Saccharomyces cerevisiae, commonly known as budding yeast, is unicellular, but grows as
individual isogenic cell colonies descended from one original cell on plated media; and was the
first eukaryotic organism to have its genome sequenced, thus making all genes and their
sequences available for study in all aspects of gene regulation, including chromatin boundary
elements. The yeast genome is relatively easy to manipulate, which makes it a very desirable
model for analyzing the mechanisms involved in chromatin remodeling and gene regulation.
Also, study of the yeast model is very desirable because many of the proteins in yeast are
conserved through evolution and are homologous to proteins in higher eukaryotic organisms,
which can provide insight into the function of genes across species. The established model for
the study of boundary elements (barriers) in Saccharomyces is best exemplified by a tRNA gene
(tDNA) on chromosome III immediately downstream of the cryptic mating-type loci, HMRa.
In Saccharomyces cerevisiae, heterochromatic silencing occurs at the cryptic-mating loci
HMRa (Homothallic Right) and HMLα (Homothallic Left), ribosomal DNA, and telomeres. In
most strains, HMLα contains a cryptic copy of the MATα genes and HMRa contains a cryptic
copy of the MATa genes (Figure 1.9). Homothallic strains of S. cerevisiae have the ability to
interconvert their mating types either from a to α, or from α to a, as frequently as once every
other generation. The ability of S. cerevisiae to switch haploid mating types depends on the HO
gene. The HO gene encodes a sequence-specific endonuclease that cleaves the mating type locus
to create a double strand break in the DNA. The repair of the cleavage occurs by a mechanism
similar to gene conversion using homologous recombination machinery, in which a silent copy
of the mating-type genes at either HMR or HML is copied into the transcriptionally active
euchromatic MAT locus (Haber 1998). Most laboratory strains do not contain an active copy of
the HO gene, so a stable haploid state can be maintained for study using various genotype
combinations after meiotic recombination and sporulation.
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Yeast Chromosome III
MAT locus – Transcribed
HM loci – Transcriptionally silenced, but identical

Figure 1.9. Schematic representation of the HMLα, MAT, and HMRa loci in S. cerevisiae.
The MAT locus is transcribed and determines cell type, a or α by expression of a1a2 or α1α2,
respectively. The cryptic HMRa and HMLα loci are located near each end of chromosome III.
Both HM loci are flanked by the E and I silencers that bind ORC1p, Rap1p, and Abf1p for the
initiation of silencing. This nucleation of sequence-dependent binding proteins is succeeded by
the binding of the silencer (Sir) proteins which propagates the silencing effect and thus the
establishment of heterochromatin.
Within the yeast nucleus, HMRa (or HMR) exists as 12 ordered nucleosomes arranged in six
pairs of closely spaced nucleosomes separated from one another by longer linkers and spans
~3.5kb of DNA (Mastrangelo, Weinstock et al. 1992; Ravindra, Weiss et al. 1999).
The sequence elements flanking both HM loci are silencing initiators termed E and I
silencers (Essential and Important). The E and I silencer elements contain ARS (Autonomously
Replicating Sequences) which are binding sites for the Origin Recognition Complex (ORC). The
E silencer is primarily responsible for the initiation of silencing with the binding of Abf1p
(Autonomously replicating sequence Binding Factor), Rap1p (Repressor Activator Protein), and
ORC; whereas the I silencer only binds Abf1p and ORC (Moazed 2001; Huang 2002). ORC and
Rap1p are only required for the initiation of silencing and not any other subsequent silencing
event. At HMR, silencing is most robust between the two silencer sequences, E and I, where the
haploid-specific cryptic mating type genes (a1a2) are positioned (Rusche, Kirchmaier et al.
2003).
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In S. cerevisiae, silenced domains consist of continuous distributions of SIR proteins along
the chromosome that are targeted by hypoacetylated nucleosomes, and are thought to form an
ordered, compact structure that restricts transcription (Hecht, Strahl-Bolsinger et al. 1996; StrahlBolsinger, Hecht et al. 1997; Lieb, Liu et al. 2001; Rusche, Kirchmaier et al. 2002).
Interestingly, the inheritance of silenced chromatin domains has been shown to be remarkably
stable during both mitosis and meiosis (Grewal and Klar 1996) and the tails of histones H3 and
H4 are unacetylated at most positions (Braunstein, Rose et al. 1993; Braunstein, Sobel et al.
1996; Suka, Suka et al. 2001).
The propagation of silent heterochromatin through HMR is sequence-independent and
mediated by the Sir proteins after the initiation of silencing at the E and I silencers. The Sir
complex, which contains Sir2p, Sir3p, and Sir4p, is recruited to the silencers through the
initiating DNA-binding proteins of ORC1p, Rap1p, and Abf1p (Figure 1.10). Sir1p binds to
ORC1p and sets the stage for the binding of the other Sir proteins. Sir4p binds next and is known
to interact with both Sir1p and Rap1p. The binding of Sir4p to the silencer does not require Sir2p
or Sir3p but instead is responsible for the initial recruitment of Sir2p. Sir4p is required for the
binding of Sir3p which also possibly binds to Abf1p. Sir2p not only functions in the structural
integrity of silencing at heterochromatic regions of yeast, but is also a histone deacetylase which
is dependent on Nicotinamide Adenine Dinucleotide (NAD+) as a cofactor (Rusche, Kirchmaier
et al. 2003).
In the propagation of heterochromatin (silencing), the enzymatic deacetylation by Sir2p of
the adjacent nucleosome coupled with the hydrolysis of NAD+ creates sites on histones where
Sir3p and Sir4p can bind with higher affinity to the N-terminal histone tails of the adjacent
nucleosomes. The Sir complex then proceeds to propagate along an array of deacetylated
nucleosomes.
20

Adapted from Rusche, Kirchmaier, and Rine, Mol. Biol. Cell, v13, p2207, 2003
Figure 1.10. Initiation and propagation of heterochromatic silencing at the E silencer
through the HMR locus in S. cerevisiae. A) Initial recruitment of DNA-binding proteins Orc1p,
Rap1p, and Abf1p along with the Sir proteins in an ordered assembly. B) Sir2p deacetylates the
adjacent nucleosome creating a high affinity binding site for Sir3p and Sir4p. C) Propagation of
silent heterochromatin begins with the deacetylation action of Sir2p and the ordered assembly of
Sir proteins. D) A repetition of this process leads to silencing of the entire region.
Downstream of the I silencer sequence at the HMR locus is a boundary element of the
barrier type which consists of a tRNAthr gene. Deletion of this tDNA (tRNA gene) can lead to a
significant loss of boundary element function. Also, mutations that affect the activity of the RNA
Polymerase III transcription factors TFIIIC or TFIIIB impairs the barrier function of this tDNA.
Disruption of the barrier can occur from tDNA mutations in the tRNAthr promoter, which
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eliminates a nucleosome-free gap by inhibiting the binding of the entire Pol III complex, or by
mutations in either the GCN5 or SAS2 genes that encode histone acetyltransferases, which affect
global chromatin processes (Donze, Adams et al. 1999). Another gene that could play a role in
the integrity of the barrier element by affecting global processes is the histone deacetylase RPD3
(Jambunathan, Martinez et al. 2005).
RPD3 or Reduced Potassium Dependency encodes the catalytic subunit of two functionally
different histone deacetylase complexes, is conserved between humans and yeast, and can either
repress or lead to activation of transcription when targeted to promoters. Two Rpd3 complexes
have been characterized and have been designated as Rpd3 small and large complexes, Rpd3(S)
and Rpd3(L). Rpd3(S) functions within coding regions of genes to prevent erroneous
transcription initiation by recognizing Set2p methylated histones (H3K36) through its Eaf3p
chromodomain where it deacetylates histones within these transcribed sequences (Carrozza, Li et
al. 2005). Rpd3(L) functions specifically at repressed promoters through contacts with DNA
binding repressor proteins (Keogh, Kurdistani et al. 2005).
Curiously, while the deletion of RPD3 leads to higher global acetylation levels, at the same
time, silencing is enhanced at the cryptic mating loci (specifically HMR) and telomeres (Vannier,
Balderes et al. 1996), even overriding the tDNA barrier element adjacent to the HMR locus
(Jambunathan, Martinez et al. 2005). In rpd3∆ mutants, it was found that a fraction of Sir2p
molecules was delocalized from the nucleolus (rDNA) and became enriched at the regions of
DNA adjacent to telomeres and at the silent HM loci (Santos-Rosa, Bannister et al. 2004;
Venkatasubrahmanyam, Hwang et al. 2007; Zhou, Zhou et al. 2009). Through our own
experimentation with an ADE2 marker gene inserted downstream of the tDNA boundary
element, strains deleted for RPD3 showed that silencing bypasses the tDNA barrier element and
represses the inserted ADE2 marker gene (Figure 1.11).
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Figure 1.11. Deletion of RPD3 affects the spreading of silencing heterochromatin at HMRa.
Both wild-type (WT) and rpd3Δ representations of the HMR region are depicted above with E
and I silencers in blue, the mating type specific genes (a1a2) in green, the barrier tRNAthr in
brown, and the inserted ADE2 gene either active (white) or silenced (red). The spreading of
silencing (represented by the red arrow) begins at the silencers and is halted at the barrier in WT
cells where the ADE2 gene is active and produces a white colony color phenotype in S.
cerevisiae cells. Silencing in rpd3Δ cells bypass the barrier element and the spreading of
silencing heterochromatin proceeds through to repress transcription of the ADE2 gene, thus
resulting in a red colony color phenotype.
The laboratory created ADE2 inserted strains harbor an intrinsic mutation in its genomic ADE2
gene, making the parent strains auxotrophic for adenine. The silencing of this ectopic ADE2 gene
results in the build-up of intermediates in the adenine biosynthesis pathway which are converted
to a red pigment and reflected as a colony color phenotype.
The silencing paradox that exists in rpd3Δ strains is evident by the fact that Rpd3p is a
histone deacetylase, the action of which is associated with heterochromatin. Intuitively, the
deletion of RPD3 should result in the increase of global histone acetylation levels and thus a
decrease or an abolishment of silencing. What is the mechanism of this rpd3Δ silencing effect?
What role would Rpd3p play in halting the enhanced spreading of silencing heterochromatin?
Are there any other extraneous effectors mediating this silencing effect? Does Rpd3p play a
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major role in boundary integrity? Rpd3 has many roles in maintaining genome integrity and one
focus of this dissertation was to study the mechanisms which lead to the enhanced silencing
effect in rpd3Δ strains of S. cerevisiae, which bypass the barrier element of tRNAthr at the HMR
loci.
Emerging studies are revealing that tDNAs not only function as transcription units for
transfer RNA molecules essential for translation and barrier elements to heterochromatic
propagation, but also perform numerous other extra-transcriptional roles which can potentially
have effects on chromatin state and genomic organization. Chromatin bound Pol III complexes
mediate the targeting of Ty element integration (Chalker and Sandmeyer 1992; Kirchner,
Connolly et al. 1995; Devine and Boeke 1996), the blocking of replication fork progression
(Deshpande and Newlon 1996), condensin and cohesin recruitment (Dubey and Gartenberg
2007; Haeusler, Pratt-Hyatt et al. 2008), and inhibition of transcription from nearby Pol II
promoters (Kinsey and Sandmeyer 1991; Hull, Erickson et al. 1994; Bolton and Boeke 2003;
Simms, Miller et al. 2004) (Figure 1.12).
Yeast TFIIIC is a large, multi-component protein of 570 kDa consisting of six polypeptides
of 138, 131, 95, 91, 60 and 55 kDa which correspond to the genes TFC3, TFC4, TFC1, TFC6,
TFC8, and TFC7 respectively. No single component of TFIIIC seems to be able to bind DNA on
its own; instead, TFIIIC tends to bind as a complete complex. Studies in both budding and fission
yeast initially identified the presence of chromosomal sequences that are bound by the TFIIIC
complex, but not the other Pol III transcription factors TFIIIA, TFIIIB, or the Pol III enzymatic
complex itself (Harismendy, Gendrel et al. 2003; Roberts, Stewart et al. 2003; Moqtaderi and
Struhl 2004; Noma, Cam et al. 2006), and similar sites have recently been identified in human
cells (Canella, Praz et al. 2010; Moqtaderi, Wang et al. 2010; Oler, Alla et al. 2010; Raha, Wang
et al. 2010).
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Figure 1.12. Extra-transcriptional effects of tDNAs. tDNAs cause a nucleosomal shift (A) 3’
to 5’overriding sequence specificity for the nucleosome (red), direct the 5’ integration of Ty
retrotransposons (B), block the progression of replication forks (C), repress Pol II genes by
proximity (D), and block the spread of silencing heterochromatin into euchromatic regions (E).
These sequences are referred to either ETC (Extra-TFIIIC) or TFIIIC-only sites in budding yeast
and humans, and COCs (Chromatin Organizing Clamps) in fission yeast (Roberts, Stewart et al.
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2003; Moqtaderi and Struhl 2004; Noma, Cam et al. 2006) and contain only the intragenic Box B
sequences of the Type II RNA Polymerase III genes (tRNAs) (Figure 1.13).

Figure 1.13. The ETC (extra-TFIIIC) site. ETC sites are conserved RNA Pol III type II
intragenic Box B sequences which are dispersed throughout the genome. The Pol III
transcription factor TFIIIC stably binds to these ETC sites which are overrepresented between
divergently transcribed RNA Pol II genes.
Interestingly, the conserved regions of ETC sites in Saccharomyces are over-represented at
divergently transcribed Pol II genes. Some of these ETC (or COCs) sites in budding and fission
yeast have been shown to function as chromatin boundary elements (Noma, Cam et al. 2006;
Simms, Dugas et al. 2008), however, the genome-wide function of most of these TFIIIC-bound
sites remains unknown. The B box sequences are highly conserved among tRNA genes (Dieci,
Percudani et al. 2000) and the interaction of TFIIIC with the B block sequence functions to some
extent in a distance- and orientation-independent manner (Burnol, Margottin et al. 1993).
ETC or TFIIIC-only loci were first identified in genome-wide distribution assays of RNA
Pol III transcription components using ChIP followed by microarray hybridization (ChIP-CHIP)
in S. cerevisiae. Eight loci were identified as having only TFIIIC occupancy and were not
occupied by any other Pol III factor and were found to be highly conserved among the four yeast
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species: S. cerevisiae, S. mikatae, S. bayanus, and S. paradoxus (Moqtaderi and Struhl 2004)
(Figure 1.14).

Modified from Moqtaderi and Struhl, Mol. Cell Bio., v24, 2004, p4123
Figure 1.14. Extra-TFIIIC (ETC) sites discovered in different Saccharomyces species. B
block alignment of ETC1 to ETC8 including the ZOD1 locus. The B block consensus is derived
from 274 tRNAs. The ETC consensus is derived from four different Saccharomyces species. The
height of each letter is directly proportional to its degree of identity across contributing species.
Adjacent Pol II genes are indicated in parentheses with a hyphen.
These sites were found to contain an eleven nucleotide consensus in S. cerevisiae, and there is
also a 100% sequence conservation of three additional nucleotides located 6 to 8 bases
downstream of the B block consensus. The final C in this sequence is significantly conserved
upon alignment of the B block of the 274 tRNA genes. Perfect conservation of the three
additional nucleotides is found at all ETC loci but in only 21 out of 274 tRNAs. The ZOD1 locus
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differs from the other ETC sites in that it is bound by all Pol III components (Moqtaderi and
Struhl 2004).
Microscopic examination of S. pombe nuclei showed that distant COC sites localize to form
a limited number of clusters at the nuclear periphery (Noma, Cam et al. 2006). COC loci in S.
pombe are also often positioned near CCCTC-binding factor (CTCF) binding sites suggesting a
possible role in chromatin insulation. A number of ETC loci also have binding motifs for the
ETS transcription factor, but the connection between ETS and TFIIIC remains unknown (Noma
and Kamakaka 2010). Under strict experimental criteria, 1,865 ETC sites were identified in
humans with the implication of several thousand more. In humans, the distribution of TFIIICoccupied loci of both ETC and non-ETC types revealed a positional bias toward the
transcriptional start sites (TSSs) of Pol II genes, as 181 ETC loci with the highest levels of TFIIIC
showed occupancy near the TSSs of Pol II genes, with 68% being located within 1kb of a Pol II
TSS (Moqtaderi, Wang et al. 2010). Also, the strongest TFIIIC-bound loci were within 200bp of
CCCTC-binding factor (CTCF) sites (Noma and Kamakaka 2010).
The purpose of this study is to further our understanding of gene regulation mediated by
boundary elements in S. cerevisiae and the mechanisms behind these particular functions.
Previous studies at HMR have shown that although the spread of heterochromatic silencing in
RPD3 mutants is not halted at the tDNA barrier, it does not appear to affect transcription of the
tRNA gene (Donze, Adams et al. 1999; Donze and Kamakaka 2001), so RPD3 must play a role
in restricting the spread of silencing at HMR. This different mechanism may involve global
changes in histone modifications which in turn can affect the recruitment of specific chromatinassociated proteins at that region. Studies of ETC sites in yeast have suggested that they may
function as chromatin boundary elements (Noma, Cam et al. 2006; Simms, Dugas et al. 2008);
and mapping of the ETC6 site to the TFC6 promoter suggested that the TFIIIC complex might be
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involved in auto-regulation of the TFC6 gene (Moqtaderi and Struhl 2004) and can potentially
function as an insulator to the targeted activation of the TFC6 promoter (Figure 1.15).

Figure 1.15. Model of autoregulation at the TFC6 locus. Schematic of the TFC6 locus
including the promoter region that contains ETC6. The divergently transcribed Pol II genes, TFC6
and ESC2, are in blue and the ETC6 site is in orange. TFC6 encodes the Tfc6p subunit (green) of
the TFIIIC transcription complex (green) that either binds to ETC6 or other RNA Pol III binding
sites. The binding of TFIIIC to ETC6 potentially functions as an insulator to the activation of
TFC6 expression by a potential UAS (blue triangles) and an unidentified UAS-bound transcription
factor.
At the TFC6 locus, our previous studies have shown that deletion of the ETC6 (B box) site
results in increased relative TFC6 gene expression, whereas deletion of ETC6 plus all sequences
upstream of ETC6 through to the transcription start site of ESC2 (the divergently transcribed Pol
II gene at the ETC6 locus) resulted in a surprising decrease of TFC6 transcription (Simms, Dugas
et al. 2008). These results suggested that the ETC6 site directly functions in the regulation of
TFC6, and that it may be due to an insulator-like activity.
In overview of this dissertation, the second chapter examines factors affecting barrier
elements by elucidating the mechanisms or effectors of the enhanced rpd3Δ silencing effect that
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bypasses the natural tRNAthr barrier at the HMR region. Using a genetic screen, we proposed to
identify potential mechanistic effectors of the rpd3Δ silencing effect and subsequently analyze
these effectors. Using UV-mutated strains of rpd3Δ cells, we identified and analyzed seven
different genes which when individually deleted, revealed that only two of the seven genes
reversed the increased silencing effect in rpd3Δ strains.
The third chapter examines a novel autoregulatory mechanism with potential insulator
activity of TFIIIC bound at ETC6 in the TFC6 promoter. Since TFIIIC binds to the B box
sequence of ETC6, we propose that TFIIIC may have a direct effect on the regulation of the TFC6
gene through either an insulator-like mechanism, or by competing for binding with an
uncharacterized transcription factor that binds immediately upstream. We also propose that this
novel function is the first known example of an RNA Polymerase III core transcription factor
(TFIIIC) directly regulating an RNA Polymerase II promoter (TFC6). Finally, chapter four will
include a more thorough discussion of the results of both studies and the implications of those
results. This section will also include new strategies for future experiments and/or directions for
these studies of barriers and insulators as boundary elements in light of new evidence.
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CHAPTER TWO
EFFECTORS OF THE RPD3 DELETE SILENCING EFFECT

38

INTRODUCTION
DNA in eukaryotic cells exists in the context of chromatin where the nucleosome is the
fundamental unit. The nucleosome consists of 147 bp of DNA wrapped 1.7 times around histone
proteins H3, H4, H2A, and H2B (2 subunits each) with N-terminal tails on each individual
histone polypeptide extending out from the nucleosome core. These N-terminal tails are partly
responsible for the compaction of chromatin and are subject to different covalent modifications
(e.g. acetylation, methylation, and phosphorylation) at specific residues. These modifications
have been shown to recruit other histone modification enzymes and/or chromatin remodeling
factors (Luger, Mader et al. 1997). A combinatorial code may exist for the distribution of both
type and location of histone modifications which can serve as molecular docking sites for the
recruitment of specific regulatory proteins and/or transcriptional machineries.
Chromatin environments display mainly two major states of architecture, euchromatin and
heterochromatin. Euchromatin is a more open state where the underlying DNA is accessible to
the transcription machinery, and heterochromatin is a more closed, condensed state of compact
nucleoproteins and additional protein complexes making the underlying DNA inaccessible to
transcription. Regulation of regions that in either open or closed states is crucial for proper gene
expression during differentiation of cell types and for overall proper genomic functioning within
living cells. Numerous protein complexes interact not only with DNA but also associated
chromatin proteins to modify particular histone proteins, to recruit ATP-dependent chromatin
modifying enzymes, and to silence certain regions of the genome (Luger, Mader et al. 1997;
Lorch, Zhang et al. 1999; Wu and Grunstein 2000).
Saccharomyces cerevisiae contains regions in its genome where the spreading of
heterochromatic silencing is essential for proper functioning of the cell. These regions include
the cryptic mating-type loci, HMRa and HMLα, the telomeric ends of chromosomes, and
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ribosomal RNA (rRNA) genes (Rusche, Kirchmaier et al. 2003). In this study, we preferentially
examined the cryptic mating locus region of HMRa, which is an ideal model for the initiation,
propagation, and establishment of heterochromatic silencing of particular mating type genes.
This silencing is initiated by the silencer sequence regions E and I that bind sequence-dependent
proteins generally involved in DNA replication and transcription activation (e.g. ORC, Rap1p,
Abf1p). Silencing is then propagated downstream of the silencer sequences, and at the mating
loci is essential in maintaining a particular yeast haploid cell mating type, a or α.
The propagation of silent heterochromatin at HMR is sequence-independent and mediated
by the binding of Silent Information Regulator (SIR) proteins. Sir2p is an NAD+-dependent
histone deacetylase that is required for silencing of heterochromatic regions in yeast. The
propagation of silencing proceeds downstream through the HMR by the deacetylation action of
Sir2p on the successive nucleosomes coupled with the hydrolysis of NAD+ and the subsequent
binding of the other Sir proteins (Sir3p, Sir4p, etc.) (Rusche, Kirchmaier et al. 2003).
Rpd3p, another histone deacetylase, is the enzymatic subunit of two characterized
complexes, Rpd3(L) and Rpd3(S). Rpd3(L) represses transcription when targeted by promoterspecific transcription factors, and Rpd3(S) prevents erroneous transcription initiation within
coding regions by recognizing Set2p methylated histones (at H3K36), where it then deacetylates
those histones within transcribed sequences (Carrozza, Li et al. 2005; Keogh, Kurdistani et al.
2005). In yeast, RPD3 deletion surprisingly enhances silencing at the cryptic mating loci and
telomeres (Vannier, Balderes et al. 1996) even overriding the tDNA barrier element adjacent to
the HMRa locus (Donze and Kamakaka 2001; Jambunathan, Martinez et al. 2005).
We hypothesized that the increased silencing in rpd3∆ mutants may be due to the derepression of genes that increase silencing. This gave us the rationale to first perform a genetic
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screen to identify potential effectors of the rpd3Δ silencing effect. To understand the mechanism
of enhanced silencing in yeast lacking RPD3 by identifying potential effectors of this silencing
effect, we used ultraviolet light to mutagenize rpd3∆ strains, which contained an inserted ADE2
marker gene downstream of the HMR locus. We identified suppressor mutants that no longer
displayed an enhanced silencing phenotype. These genes were subject to individual gene
replacements with the LEU2 marker gene (knockouts) and crossed back to an rpd3Δ background
and assessed for a change in colony color phenotype.
At HMR in wild-type strains, the tRNAthr gene functions as a barrier element that blocks the
spread of silencing into an ectopic ADE2 marker gene. In rpd3∆ strains, silencing spreads past
the barrier element and into the downstream ADE2 gene, thus silencing the expression of this
gene. Silencing of the ADE2 gene results in accumulation and polymerization of Pribosylaminoimidazole (AIR) molecules in the adenine biosynthesis pathway which results in a
red/pink pigment reflected in yeast colony color. Since Sir-dependent mediated silencing also
occurs at telomeres, we also took advantage of an inserted telomeric URA3 gene on chromosome
VII-L to assess Sir-mediated silencing at telomeres in our genetic screen and test for mechanistic
consistencies between the HMR and the telomere.
From this genetic screen, we identified seven genes which when disrupted reversed the
extended heterochromatin formation at HMR in rpd3∆ backgrounds: BRE1, GDH2, BRE2,
GAT3, QNS1, NPT1 and RXT3. It has been previously shown that NAD+ biosynthesis pathway
genes (NPT1 and PNC1) are either directly or indirectly involved in the regulation of Sir2p
activity and silencing at rDNA and telomeres (Sandmeier, Celic et al. 2002), therefore we asked
if expression levels of those genes were altered by deletion of RPD3. Using Northern analysis to
assess the expression of these NAD+ biosynthesis pathway genes, our studies showed no
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difference in the expression levels of the genes NPT1, QNS1, or PNC1, between our WT and
rpd3∆ strains. These genes were not studied further as potential effectors. There was also the
potential that Rpd3p, which complexes with Ume6p to repress promoter regions, could act as a
repressive transcription factor for GDH2 expression. The product of GDH2 is an NAD+dependent glutamine dehydrogenase, so the requirements of Gdh2p could potentially be affected
by the availability of Sir2p and its enzymatic requirements of NAD+ (Kurdistani, Robyr et al.
2002). Also, the only yeast H3K4 trimethyl demethylase, Jhd2p, contains a JmjC domain which
has been shown to directly remove lysine methylation via a hydroxylation reaction that requires
iron and α-ketoglutarate as cofactors (Klose, Kallin et al. 2006; Tsukada, Fang et al. 2006).
Because glutamate dehydrogenase (GDH2) degrades glutamate to ammonia and α-ketoglutarate,
it may indirectly participate in the demethylation of histone H3K4 through Jhd2p.
Of the five genes that were knocked out and crossed back to an rpd3 strain, only the bre1∆
and bre2∆ gene knockouts showed a loss of extended silencing at HMR. Interestingly, there was
no loss of telomeric silencing in both the double knockout strains, as growth on 5-FOA (5flouro-orotic acid) demonstrated that the inserted URA3 gene proximal to telomeres was not
expressed. BRE1 and BRE2 are both either indirectly or directly required for the trimethylation
of H3K79 and H3K4, which is required for the proper regulation of silencing at HMR, rDNA,
and telomeres (Fingerman, Wu et al. 2005). Our initial experimentation through ChIP assays did
not show any differences in H3K4 trimethylation along the HMR region or regions downstream
of HMR between WT and rpd3Δ strains.
Other studies involving histone H3K4 methylation have suggested that mutations in the
methylation establishment pathway can lead to a re-distribution of Sir proteins at silenced loci
(Tompa and Madhani 2007; Venkatasubrahmanyam, Hwang et al. 2007; Zhou, Zhou et al. 2009;
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Ehrentraut, Weber et al. 2010). In light of this new evidence, we have modified our hypothesis of
the rpd3∆ silencing effect to take into account the limited availability of Sir proteins in the cell.
Our adjusted hypothesis includes the supposition that rpd3Δ strains result in an increase in the
global acetylation of nucleosomes in euchromatic regions; this altered acetylation state can
potentially cause a shift of the localization of the limited pool of Sir proteins, as their binding to
some regions would be inhibited by acetylated histones, freeing them to concentrate at silenced
telomeric and HMR regions. This adjusted hypothesis and the description of future studies,
which will include the utilization of Sir proteins fused with a functionally repressed E. coli DNA
methyltransferase, will be addressed in more detail in the final discussion chapter.
MATERIALS AND METHODS
All yeast strains used in this study are isogenic to W303-1a except where noted. The original
parent rpd3Δ strain (DDY 3133) containing ADE2 downstream of HMR used for ultraviolet
mutagenesis in the genetic screen was created previously in our lab as described (Jambunathan,
Martinez et al. 2005). All oligonucleotides utilized in this study are listed in Table 2.1.
Yeast Genomic DNA Extraction (Winston Prep)
A 4 mL yeast overnight culture was grown in YPD (Yeast extract Peptone Dextrose) media
or YMD (Yeast Minimal Dextrose media if selecting for a plasmid) at 30ºC with rotation for
aeration. The overnight culture was spun at 2000 rpm for 5 min. The supernatant was aspirated
and the pellet was resuspended in 400 μL of Winston solution (2% Triton X-100, 1% SDS, 100
mM NaCl, 10 mM Tris HCl pH8.0 and 1 mM EDTA). The cell suspension was then added to a
microfuge tube containing ~300 μL of glass beads and 300 μL of phenol/chloroform. The
samples were vortexed for 5 min in a multi-vortexer at high speed, spun for 5 min at high speed
and the supernatant removed and added to another tube containing 300 μL of phenol/chloroform
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for another extraction. The samples were then vortexed for ~15 sec and spun for another 5 min.
The supernatant was removed and added to a tube containing 1 mL of absolute ethanol, mixed
well and incubated at room temperature for 5-10 min. The samples were then spun for 10 min at
room temperature or 4ºC and the ethanol was aspirated. The pellet was air-dried and resuspended
in 80 μL of TE containing RNase A (60 μg/mL)
Yeast High Efficiency Transformation
Yeast cultures were grown in YPD at 30ºC with constant shaking to an Optical Density
(O.D.) at 600 nm of 0.7, and the pelleted cells were resuspended in 1X TEL (1 mL of 1X TEL
per 10 mL culture) and were left to rock overnight at room temperature. The next day cells were
pelleted, resuspended in 100 μL of 1X TEL per 10 mL culture incubated at room temperature for
30 min. 100 μL of competent cells, 5 μL of 10 mg/mL Salmon sperm DNA and 1 μg of the
plasmid DNA were mixed in an eppendorf tube and incubated again for 30 min. 700 μL of 40%
PEG/TEL was added to each tube and incubated at room temperature for 60 min without
shaking. 88 μL of DMSO was added to each tube, mixed and the cells were subjected to heat
shock at 42ºC for 10 min. The cells were spun gently at 8000 rpm for 30 sec, pellets washed with
300 μL of water and resuspended in 400 μL of water. 200 μL was plated on to two YM selection
plates.
Yeast RNA Extraction
A culture of 35 mL was grown to an optical density of 1.0. The cells were pelleted and
washed with 1 mL of DEPC water and resuspended in 1 mL of extraction buffer (50 mM
NaOAc, 10 mM EDTA, HOAC pH 5.0). 120 μL of 10% SDS was added and vortexed and cells
were frozen at -80ºC. 1.2 mL of phenol equilibrated in NaOAc extraction buffer was prewarmed
to 65ºC and added to the cells and mixed well. Samples were then incubated in a water bath set

44

at 65ºC with constant shaking for one hour and then cooled on ice for 5 min. The tubes were then
spun for 10 min at high speed and the top aqueous layer was removed and re-extracted with
another 1 mL of equilibrated phenol. Samples were spun again and the aqueous phase was
extracted with 1 mL of phenol/chloroform equilibrated in ANE buffer (10 mM NaOAc, 100 mM
NaCl, 1 mM EDTA pH 6.0). RNA was then precipitated with 1/10 volume of 3 M NaOAc and
1.4 mL of absolute ethanol at -20ºC for 30 min to overnight. The RNA was pelleted by
centrifugation for 10 min at 4ºC and washed with 300 μL of 70% ethanol (diluted in DEPC
water), air dried and resuspended in 600 μL of DEPC water. Concentration (µg/µL) was
determined by measuring UV absorbance at 260 nm.
Northern Blot Analysis
Yeast cultures were grown in YPD and total RNA was extracted as described above. 10 μg
of total RNA for each sample was resolved on a MOPS/formaldehyde/agarose gel and blotted to
Zeta–Probe (Bio-Rad) membrane by wicking in transfer buffer (0.01 N NaOH + 3 M NaCl).
PCR-generated double-stranded DNA containing the T7 promoter and region of homology to
mRNA target was used as the template in the generation of a radioactive RNA antisense probe.
The probes were 32P-α-UTP-labeled in a T7 polymerase in vitro transcription reaction at 37ºC for
30 min to 1 hr. Zeta-probe membrane was incubated in ULTRAhyb (Ambion) for a prehybridization step. The radioactive probe was filtered to remove unincorporated UTP and added
to the membrane. Hybridization was carried out overnight at 65ºC. Membranes were washed
twice in 2X SSC for 5 min each in 65ºC, then washed twice in 0.1X SSC for 15 min each in
65ºC. Zeta-probe membrane was then placed under phosphor screen in exposure cassette for 2 hr
to overnight and scanned using Typhoon scanner (LSU Genomics Facility). The PCR-generated
double-stranded DNA used to generate the RNA probes are as follows: PNC1 (DDO 898/899),
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NPT1 (DDO 900/901), QNS1 (DDO 906/907), NMA1 (DDO 902/903), and NMA2 (DDO
904/905).
Genetic Screen of UV-mutated rpd3Δ Strains
For the genetic screen, rpd3Δ cells (DDY 3133) were diluted and plated on YPD media for
single cells and subjected to 12 sec doses of 200 µJ of ultraviolet light to initiate random
mutations in the yeast genome of each plated cell. After two days of growth on YPD, white
colonies were isolated and used for the library transformation to complement and identify the
mutated genes. 250 ng of genomic library plasmid DNA (total conc. 0.84 µg/µL), containing a
yeast LEU2 marker and a bacterial AMP-resistant (AMPr) gene (Courtesy of J. Rine) was
transformed by high efficiency yeast transformation (see described) to produce ~500 colonies
plated on YMD –leu, 30% adenine. Approximately 6000 colonies were screened for each round
of transformations. The transformed cells were plated on YMD –leu, 30% adenine to produce
optimal red/pink pigmented colonies if the ADE2 gene is silenced. Twenty-four high efficiency
transformations of the library plasmid were performed and two transformations were plated on
100 mm plates (12 total), including one negative control plate with no plasmid DNA. The
red/pink colonies were patched to –leu 30% ADE, -leu, -ura (for URA3 marker at the telomere),
and 5-FOA (5-flouroorotic acid) + all mix (growth due to silencing of URA3) plates. Positive
growth patches were inoculated in YMD –leu, 30% ADE and yeast genomic DNA extracted (See
Winston prep described). Yeast total DNA was cleaned and eluted in 50 µL water using PCRclean up kit (Zymo #D4003). 3 µL of yeast total DNA (containing library plasmid) was
electroporated (2.5 kV, 25 µF, 200 Ω) into 40 µL of electrocompetent E. coli (DH5α) and plated
on 2xyt+ampicillin bacterial media. Library plasmid DNA was extracted from ampicillinresistant bacteria colonies (alkaline lysis miniprep) and recovered plasmid was digested with
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EcoRI to detect restriction patterns different from those of previously recovered library plasmids
containing normal heterochromatin-complementing genes such as SIR2, SIR3, etc. Recovered
plasmids containing potential effector open reading frames (ORFs) were re-transformed back
into the original UV-mutated strain they were first transformed into and analyzed for
complementation by the phenotypic change of colony color from white (mutated effector) to
red/pink (complement gene). Plasmids with positive complementation were then sequenced
(LSU Genomics Facility) using plasmid-specific primers (DDO 821/822) and the sequences
were BLAST searched through the SGD (Saccharomyces Genome Database) (Guldener,
Munsterkotter et al. 2005).
Gene Knockouts (LEU2 Replacements)
Gene Knockouts were generated by first PCR amplifying LEU2 from plasmid template
pDD672 with primers having regions of homology to both the plasmid carrying the LEU2 gene,
and the flanking regions of the genes being deleted. Eight PCR reactions containing the 2.3 kb
LEU2 PCR product were verified by gel electrophoresis and purified using PCR clean-up kit
(Qiagen). The linear double-stranded DNA carrying the LEU2 gene was transformed into DDY
3161 and 3160 by high efficiency transformation as described. Cells were plated on YMD -leu to
select for positive LEU2 integrants. DNA was extracted from Leu+ isolates and checked for
proper integration by upstream and downstream PCR. DDO oligos for PCR check for upstream
and downstream integration: BRE1 (914/198) and (915/199), GDH2 (918/198) and (919/199),
BRE2 (927/198) and (928/199), GAT3 (931/198) and (932/199), RXT3 (935/198) and (936/199);
198 and 199 were interchanged with 823 and 824 (Table 2.1).
Plasmid Gap Repair of wild-type and UV-mutated BRE1 and BRE2 alleles were generated
by PCR-amplified upstream and downstream genomic ends: BRE1 (DDO 1007/1008) Up and
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(DDO 1009/1010) Down, BRE2 (DDO 1016/1017) Up and (DDO 1018/1019) Down in parent
strain DDY3. Amplified PCR products from both up and downstream for both genes were
digested with Pac I at the integrated site. The upstream fragment for both genes was also
digested with Sal I. The downstream fragment for BRE1 was digested with Xba I and the
downstream fragment for BRE2 was digested with Not I. All restriction sites were integrated
through PCR amplification of the genomic ends. The upstream and downstream fragments for
BRE1 were ligated into pCR2.1 (TOPO-Invitrogen) and subcloned into pDD637 (LEU2). The
upstream and downstream fragments for BRE2 were ligated into pCR4 (TOPO-Invitrogen) and
subcloned into pDD637. Both pCR2.1 and pCR4 were double-digested with Sal I/Xba I for
ligation of the BRE1 fragments (into pCR2.1) and Sal I/Not I for ligation of the BRE2 fragments
(into pCR4); both inserts were then subcloned into pDD637, which generated new plasmids,
pDD1163 and pDD1165. Both plasmids (1163 and 1165) were digested with Pac I to linearize
the DNA and transformed into DDY 3 to rescue the wild-type allele by gap repair recombination
(Orr-Weaver and Szostak 1983). The newly generated BRE1 plasmid (pDD1166) was
transformed into UV-mutated strain DDY 3883 to verify rescue of the UV induced mutation, and
the BRE2 plasmid was transformed into DDY3971.
Chromatin Immunoprecipitation Assays
Chromatin Immunoprecipitation (ChIP) was done according to (Kuo and Allis 1999). Wildtype and rpd3Δ cultures were grown in YPD to an optical density of 1.5 at 600 nm. The cells
were then fixed with 3.25 mL of 37% formaldehyde (Fisher #F79-1) and incubated at room
temperature for 20 min with gentle swirling. Cells were pelleted and washed once with 10 mL of
1X Phosphate Buffered Saline (PBS) (pH 7.4). Cells were resuspended in lysis buffer (50 mM
HEPES-KOH, pH 7.5, 140 mM NaCl, 1% Triton X-100 and 0.1% Sodium deoxycholate)
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containing the protease inhibitors, pepstatin A (1 μg/mL), leupeptin (1 μg/mL) and PMSF (100
mM), and then lysed by vortexing with glass beads for 40 min at 4ºC. The lysate tube was then
placed into another open tube containing 10 µL of PMSF by poking the bottom of the sample
tube containing glass beads with a hot 0.5 gauge needle, spun for a few seconds and collected
into the new tube. To fragment the chromatin to suitable immunoprecipitate size (200-1000 bp),
the lysate was sonicated six times for 10 sec each at 25% amplitude (Branson sonicator) with 0.9
sec intermittent pulses for a total of 10 sec and keeping the samples on ice ~1 min between
sonication cycles. The samples were then spun at 13,200 rpm for 10 min in 4ºC to pellet
insoluble material. The supernatant containing soluble chromatin was collected as whole cell
extract (WCE) and used for further analysis. 100 μL of lysate was mixed with 300 μL of lysis
buffer containing the protease inhibitors. Then the mixture was incubated in protein A sepharose
beads (Amersham Biosciences), that were washed thrice with lysis buffer containing protease
inhibitors and resuspended in lysis buffer containing 200 μg/mL of salmon sperm DNA and 500
μg/mL BSA, and rocked for 30 min at 4ºC. The beads were then spun out and 5 μL of antibody
(H3K4me3) (Abcam #ab8580-100, ~1 mg/mL) was added to the supernatant. The samples were
incubated overnight at 4ºC with gentle rocking. The antibody reactions were spun and the
supernatant was transferred to fresh tubes. 30 μL of washed and equilibrated beads was added
and the samples were incubated at 4ºC for 1 hour on a rotating nutator to pull down the antibodybound H3K4me3 histone proteins cross-linked to their respective DNA locus. The tubes were
spun again and the supernatant was transferred to fresh tubes as unbound fractions. The beads
were washed for 5 min each with 1 mL of the following buffers: i) Lysis buffer with protease
inhibitors, ii) Wash buffer I (Lysis buffer + 500 mM NaCl), iii) Wash buffer II (10 mM Tris 8.0,
250 mM LiCl, 0.5% NP-40, 0.5% Sodium Deoxycholate, 1 mM EDTA), and iv) TE (1X). After
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TE wash, the tubes were spun again to remove any residual liquid. After this step, an efficient
and rapid Chelex-resin based procedure was used to isolate PCR-ready DNA (Nelson, Denisenko
et al. 2006). This method utilizes 100 μL of 10% Chelex-100 (10 g/100 mL H2O, Bio-Rad)
added to the washed protein A beads and vortexed. Samples were boiled for 10 min, cooled, and
1 μL of Proteinase K (100 μg/mL) was added and the beads were incubated for 30min at 55C
while shaking, then boiled for another 10min. The suspension was centrifuged and the
supernatant was collected. The Chelex/protein A beads fraction was vortexed with another 100
μL water, centrifuged again, and the supernatant was combined with the previous supernatant.
The eluate was used directly in the PCR reaction. For input controls 10 μL of the whole cell
extract was mixed with 475 μL of Elution buffer (1% SDS, 0.1 M NaHCO3), and 20 μL of 5 M
NaCl. The tubes were incubated at 65ºC (four hours to overnight) to reverse the protein/DNA
crosslinks. To each tube 20 μL of 1M Tris pH 8.0, 10 μL of 0.5 M EDTA and 1 μL of Roche
Proteinase K (20 mg/mL) was added and incubated at 55ºC for 30 min. The sample was
extracted once with phenol/chloroform, and then precipitated in 50 μL of NaOAc, 1 μL of
glycogen (Roche, 20 mg/mL stock), and 1 mL of absolute ethanol and precipitated at -20ºC. The
samples were then spun at 4ºC for 10 min and the pellets washed with 300 μL of 70% ethanol,
air dried and redissolved in 200 μL TE + RNaseA (60 μg/mL).
Table 2.1. Oligos used in this study:
Oligo

Sequence

DDO 59
DDO 60
DDO 184
DDO 198
DDO 199
DDO 478
DDO 479
DDO 480
DDO 481
DDO 482
DDO 483
DDO 484

5’-GAATTCGTTAACGGATCCCATACTCGAAGGGTAGTTGG-3’ – tRNA Up
5’-GAATTCGTTAACGGATCCGATTTTTCCATTCGCCATGC-3’ – tRNA Down
5’-GTAATACGACTCACTATAGGGC-3’ – T7 Primer
5’-GCACTCTCAGTACAATCTGC-3’ - pRS universal RC, upstream
5’-CCGCACAGATGCGTAAGGAG-3’ - pRS universal RC, downstream
5’-TGACTAAAGTAGAGCAACATACATT-3’ – HMR B-1
5’-TCTCATACGTTTATTTATGAACTAC-3’ – HMR B-2
5’-TCAATGATTAAAATAGCATAGTCGG-3’ – HMR C-1
5’-CAATAGCAATTGTATAAACACATAG-3’ – HMR C-2
5’-GGCGATATAATTTATCATGTTTTGG-3’ – HMR D-1
5’-TCTCTAACTTCGTTGACAAATTTTC-3’ – HMR D-2
5’-CCAATTCCGCATCTGCAGATTACTT-3’ – HMR-tDNA-E1

(Table 2.1 continued)
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DDO 485
DDO 595
DDO 596
DDO 821
DDO 822
DDO 823
DDO 824
DDO 901
DDO 902
DDO 903
DDO 904
DDO 905
DDO 906
DDO 907
DDO 912
DDO 913
DDO 914
DDO 915
DDO 916
DDO 917
DDO 918
DDO 919
DDO 925
DDO 926
DDO 927
DDO 928
DDO 929
DDO 930
DDO 931
DDO 932
DDO 933
DDO 934
DDO 935
DDO 936
DDO 1007
DDO 1008
DDO 1009
DDO 1010
DDO 1011
DDO 1016
DDO 1017
DDO 1018
DDO 1019
DDO 1020
DDO 1025
DDO 1026
DDO 1027
DDO 1028
DDO 1029
DDO 1030

5’-TTCATTATTTTTCAGATGACGATGG-3’ – HMR-tDNA-E2
5’-CCGTCCAAGTTATGAGCTTA-3’ - HMR A-1
5’-GCCTACCTTCTTGAACAAGA-3’ - HMR A-2
5’-ATTTCTATGCGCACCCGTTC-3’ - pBR322 Bam HI site sequencing fwd
5’-AAGTGGCGAGCCCGATCTTC-3’ - pBR322 Bam HI site sequencing rev (230 BP APART)
5’-ATCTTCTTAGGGGCAGACAT-3’ - LEU2 upstream CDS
5’-GAAGTTAAGAAAATCCTTGCTTA-3’ - LEU2 downstream CDS
5’-TAATACGACTCACTATAGGTTCACAGCTTTCATGATTCCTTG-3’ - NPT1 T7
5’-ATGGATCCCACAAGAGCTCCG-3’ - NMA1 Northern
5’-TAATACGACTCACTATAGGACTTCAAACCTTGTTTGTTCAG-3’ - NMA1 T7
5’-ATGGATCCCACCAAAGCACCC-3’ - NMA2 Northern
5’-TAATACGACTCACTATAGAGAAAAATAACCACCAACCACTTC-3’ - NMA2 T7
5’-ATGTCACATCTTATCACTTTAGC-3’ - QNS1 Northern
5’-TAATACGACTCACTATAGAGATGAGTTTGTCATGATTTCCAC-3’ - QNS1 T7
5’-AGGGCTTTCACCGTTTTTATGCTAATCGTGCTAGCTGATAATAATCAGATGCAGATTGTACTGAGAGTGC-3’BRE1 PRS KO UPSTREAM
5’-TATGTGGAGGATATAACACAAACAGTGGAAAAGTGGTAGAATAATTAGTACTTCTTACGCATCTGTGCGG-3’BRE1 PRS KO DOWNSTREAM
5’-AATATTGGGAAAATCACTGGTG-3’ - BRE1 KO UPSTREAM CHECK 386 BP
5’-GAACAAGCGCGATTAAGGTC-3’ - BRE1 KO DOWNSTREAM CHECK 327 BP
5’-AAACATACAAAACAAGGATATTAAATTCACAACAATAAAAAGAATAAAGAGCAGATTGTACTGAGAGTGC-3’GDH2 PRS KO UPSTREAM
5’-TTTCTTTTCTGACGGCAGAACTAATTTATACAAAACAATTTTATTGAAGCCTCCTTACGCATCTGTGCGG-3’GDH2 PRS KO DOWNSTREAM
5’-AAACCAAGTCCGCTTGAAAAG -3’ - GDH2 KO UPSTREAM CHECK 398 BP
5’-ACGGCTTGAATCGCATACTTG -3’ - GDH2 KO DOWNSTREAM CHECK 450 BP
5’-GATAAAGGTGGCCATAATTGGACGAAGACAAATAATTCACTTCCTTAATAGCAGATTGTACTGAGAGTGC-3’BRE2 PRS KO UPSTREAM
5’-TAAGAAACACACTTTCAGTGTGTTTTAATTATTCTTCTTTGAATGCTGCTCTCCTTACGCATCTGTGCGG-3’BRE2 PRS KO DOWNSTREAM
5’-CAATCGACATCGTTTACATGCAG-3’ - BRE2 KO UPSTREAM CHECK 380 BP
5’-AGGAGCTGTTATTTAGTCGGTCG-3’ - BRE2 KO DOWNSTREAM CHECK 390 BP
5’-AAACAATTATCAACTAGAAGCAAATATAAAGCCAGAAGGAAGAATTTGCTGCAGATTGTACTGAGAGTGC-3’GAT3 PRS KO UPSTREAM
5’-ATCACTGCTTTGACATAAGTATATAACATTCCGAGCAGAAATAAATTCTCCTCCTTACGCATCTGTGCGG-3’GAT3 PRS KO DOWNSTREAM
5’-CATACTCACACAAACACCTGTAG-3’ - GAT3 KO UPSTREAM CHECK 426 BP
5’-TGATAGAAGCAACAGTCCATTGAG-3’ - GAT3 KO DOWNSTREAM CHECK 350 BP
5’-TACTCGCAGTTTTTTTTTTGAGAGAAGTAACAATACAATATAAGATAAAAGCAGATTGTACTGAGAGTGC-3’RXT3 PRS KO UPSTREAM
5’-GCCAACTAAGGTTGGAAGGGAAAGAAGGACGACCAATATTATGTCTTTCCCTCCTTACGCATCTGTGCGG-3’RXT3 PRS KO DOWNSTREAM
5’-ACTGTCCACGAAGGCAGATTGTC-3’ - RXT3 KO UPSTREAM CHECK 371 BP
5’-ATATCGTTTACTACCGATTCGG-3’ - RXT3 KO DOWNSTREAM CHECK 365 BP
5’-AGAAATCAAAATGTCGACGTTTGTTATGCAATGAATGGTCAG-3’-BRE1 GAP 5'SAL I
5’-GATCATATTGCTTTAATTAAATGGGTCCTGCCATACATAATC-3’-BRE1 GAP 5'PAC I
5’-CTAACTTCTGAATTAATTAATGACGTCTACTGTCGCATGTTTC-3’-BRE1 GAP 3'PAC I
5’-CATAATTCATTCGCTCTAGACAAAACATAGAGCAGCAAGAAGC-3’-BRE1 GAP 3'XBA I
5’-CACCAGTGATTTTCCCAATATTATC-3’ - BRE1 GAP REPAIR CHECK WITH T7 ~670 BP
5’-TTCCGCTCTTGCGTCGACAGTCATAGGGCTGCCTGTCTC-3’ - BRE2 GAP REPAIR 5'SAL I
5’-TTCTCCTAATATTTAATTAACCAAATCTAGAACTGCATGTAAAC-3’-BRE2 GAP 5'PAC I
5’-GGTTATACATTCTTAATTAAGAGTTCGTAATCGTTATCTTCTTC-3’ - BRE2 GAP 3'PAC I
5’-GCTATTTCTCCAGCGGCCGCCATGGATATGCTAGGACTGGAG-3 - BRE2 GAP 3'NOT I
5’-ATAGAACAGATTTATCAAAAAGAGGAG -3’ - BRE2 GAP REPAIR CHECK WITH T7 ~600 BP
5’-AGATCTCTTACGGCTTATGATTG-3’ - HMR AT ADE2 JUNCTION – F1
5’-TGTCTTTGATTCTTTTAAGAAAAG -3’ - ADE2 CHIP WITH 1025 – F2
5’-CATAACACTGACATCTTTAACAAC -3’ - ADE2 START CODON CHIP WITH 1028 – G1
5’-CTAATATACCAACTGTTCTAGAATC-3’ - ADE2 START CODON CHIP WITH 1027 – G2
5’-GATTCTAGAACAGTTGGTATATTAG-3’ - ADE2 INTRAGENIC CHIP WITH 1030 – H1
5’-CAATCTGATTGTTTCTGGAGAAG-3’ - ADE2 INTRAGENIC CHIP WITH 1029 – H2

RESULTS
Genetic Screen of Genomic Library Transformed Into Ultraviolet-Mutated rpd3∆ Strains.
RPD3 deleted strains exhibit a red pigment phenotype due to the ectopic silencing of a
downstream ADE2 marker gene. This marker gives an indication of whether or not silencing has
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spread from HMR through the tRNA barrier element to repress ADE2 expression and can be
optimally assessed by growth on minimal media with 15-30% adenine supplement (Figure 2.1).

Figure 2.1. Visual and schematic representations comparing the wild-type and rpd3Δ
colony color phenotype. Wild-type colonies of Saccharomyces typically show a white to cream
color demonstrating that the spread of silencing heterochromatin from the silencer sequences at
HMR is halted at the tRNAthr barrier allowing the inserted downstream ADE2 gene to be
expressed. rpd3Δ colonies repress expression of the inserted downstream ADE2 gene and can
display a pink to a much darker red color depending on the degree of silencing of the ADE2 gene
in each cell of the colony and the free adenine available in the growth media. The strains shown
are DDY 3136 (WT) and DDY 3133 (rpd3Δ).
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We also assessed effects of silencing at the telomeres, as the HMR-ADE2 strain also contained an
inserted URA3 marker on chromosome VII proximal to the telomere ends. URA3 expression was
assessed by growth on minimal media containing 5-FOA (Boeke, LaCroute et al. 1984).
Subjecting rpd3∆ strains with doses of UV-radiation typically induces random mutations in the
yeast genome such as point mutations and pyrimidine dimers. Phenotypical analysis of any such
mutations that would cause a loss-of-function in a potential effector of the increased silencing
effect should show a reversion of colony color from the red/pink of rpd3Δ to the wild-type
white/cream.
For establishing these random mutations across the yeast genome, rpd3Δ cells (DDY 3133)
were spread on YPD plates for the growth of isogenic yeast colonies derived from a single
colony. The plates were then exposed to 200 µJ of ultraviolet light for ~20 sec. Nine YPD plates
with rpd3Δ cells were treated with ultraviolet light and three were untreated control plates. After
UV exposure and growth at 30ºC for two days, colonies containing mutations resulting in
reversion from the red colony color to the white colony color phenotype were isolated. UVmutagenesis produced 27 isolates (white colonies) from rpd3Δ strains after screening over
20,000 colonies. The colony isolates change to a white color was verified by second streaks on
YPD media and YMD+all with 30% adenine.
Individual mutated isolates were then transformed with a genomic plasmid library by high
efficiency transformation (see Methods) and plated on YMD -leu to select for cells containing
the library plasmids and grown at 30ºC for two to three days. Colony growth analysis was to
strictly observe any growing colonies that had reverted back to the original red colony color
phenotype, suggesting either complementation or suppression of the UV induced mutation. The
genomic library plasmids contained average insert sizes of 8-12 kb. Because of the compact
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nature of the yeast genome, each plasmid contained multiple ORFs, thus verification of potential
ORFs would require analysis of individual genes contained on each plasmid. 18 out of the 27
white colony revertant UV-mutated strains exhibited red colony isolates after transformation of
the genomic plasmid library after screening >12,000 colonies per strain transformed (Table 2.2).
Table 2.2. UV-mutated rpd3∆ strains transformed with potential effector genes from
genomic library plasmids.

Listed are the 18 HMR-ADE2 UV-mutated rpd3∆ strains (white) that, upon genomic library
transformation, gave rise to isolates that had reverted to the original rpd3∆ colony color
phenotype (pink). After plasmid rescue, the plasmid inserts were sequenced and analyzed for any
genes that were potentially involved in the silencing effect. The genotype of each strain is
isogenic and listed in Table 2.4.
The newly transformed colonies exhibiting red colony color were isolated and the
transformed plasmid containing the potential effector was recovered through yeast DNA
extraction (Winston prep - see Methods). To recover the library plasmid, the Winston prep DNA
was electroporated into E. coli for plasmid amplification and subsequent analysis. The genomic
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library plasmids contained an ampicillin resistant gene which was used to select for E. coli cells
that had retained the library plasmid on 2xyt+ampicillin bacterial media. After DNA extraction
from the E. coli cells, the candidate library plasmid was subjected to restriction analysis using
EcoRI and known sites in the plasmid vector to analyze any unique restriction patterns that
differed from what was seen from recovered plasmids that contained any normal
heterochromatin-complementing genes such as SIR2, SIR3, etc. The library plasmids were then
sequenced using library plasmid-specific primers (DDO 821-Up and DDO 822-Down) to
determine if any ORFs within the plasmid insert could be directly or indirectly responsible for
participating in the silencing effect or the establishment of heterochromatin. The recovered
plasmid insert sequences were BLAST (Basic Local Alignment Search Tool) searched using the
Saccharomyces Genome Database (SGD) (Guldener, Munsterkotter et al. 2005).
We identified seven genes outside the normal heterochromatin-forming complement that
were highly ranked as potential effectors of the silencing effect. These genes were BRE1, BRE2,
GDH2, GAT3, RXT3, QNS1, and NPT1. Table 2.2 lists the 18 white colony strains with the
number of revertants (minipreps) for each set of transformations. Any isolate containing a
potential effector listed in red was used for complementation analysis. As expected in this
particular genetic screen, we identified a number of recovered plasmids containing SIR genes,
mainly SIR3 and SIR4, a few of which are also listed in Table 2.2. Each of the seven genes
identified in the genetic screen are functionally described as follows: QNS1 - glutaminedependent NAD+ synthetase; NPT1 - nicotinate phosphoribosyltransferase, acts in salvage
pathway of NAD+ biosynthesis; BRE1 - E3 ubiquitin ligase for Rad6p, required for the
recruitment of Rad6p to promoter chromatin and ubiquitylation of histone H2B on K123;
H2BK123 ubiquitylation is required for subsequent methylation of histone H3 (K4 and K79);
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GDH2 – NAD+-dependent glutamate dehydrogenase, which converts glutamate to αketoglutarate; BRE2 - Subunit of the COMPASS (Set1c) complex, which methylates histone
H3K4; GAT3 - Protein containing GATA family zinc finger motifs (transcription factor activity);
RXT3 - Subunit of Rpd3(L) complex; contributes to histone deacetylase activity and
transcriptional repression.
QNS1, glutamine-dependent NAD+ synthetase, was recovered in three separate isolates after
library plasmid transformation and NPT1, nicotinate phosphoribosyltransferase, was found in
one. Also found in the genetic screen were two isolates of BRE1, E3 ubiquitin ligase for Rad6p,
four isolates of BRE2, subunit of the COMPASS (Set1c) complex, two isolates of GDH2, NAD+dependent glutamate dehydrogenase, three isolates of GAT3, GATA family zinc finger motifs,
and two isolates of RXT3, subunit of Rpd3(L) complex. BRE2 and GAT3 are two genes which
are in close approximation to each other (~2 kb) in the S.cerevisiae genome and two isolates
recovered contained both ORFs. BRE2 and GAT3 were individually identified as effectors since
we recovered two independent plasmid isolates containing only the BRE2 ORF and one
independent plasmid isolate containing only the GAT3 ORF. For complementation analysis, all
library plasmids that were recovered and identified as having potential effectors were retransformed back into their original UV-mutated rpd3Δ strain (white colonies). All strains, after
plasmid complementation, showed a colony color phenotype change from white to red, thus
further verifying that the recovered library plasmids contained genes that were potential
effectors.
Northern Analysis of NAD+ Biosynthesis Genes in Wild-Type vs. rpd3Δ Cells
Since we identified multiple genes that potentially affect NAD+ levels in cells, we pursued
this class of genes first. The deacetylation reaction of H4K16 by Sir2p, and thus the propagation
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of silencing, relies on the cofactor nicotinamide adenine dinucleotide (NAD+) to catalyze the
deacetylation reaction (Imai, Armstrong et al. 2000; Landry, Slama et al. 2000; Smith,
Brachmann et al. 2000). Two of the genes identified in the genetic screen, QNS1 and NPT1, are
components of the NAD+ biosynthesis pathway. Since the NAD+-coupled Sir2p deacetylase
reaction is the foundation of heterochromatic silencing at HMR, we hypothesized that RPD3
could either be directly or indirectly involved in the regulation of these pathway genes and thus
the expression of these two genes may affect Sir2p activity. The rationale is that Rpd3p may
function as a repressor of QNS1 or NPT1 expression at their own promoters and thus the deletion
of RPD3 may enhance the expression of these genes which can result in increased availability of
NAD+ as a cofactor for the enzymatic action of Sir2p at the HMR region.
We performed a Northern analysis on the two genes identified in the screen, QNS1 and
NPT1, and included the gene PNC1 which is responsible for the conversion of nicotinamide to
nicotinic acid and thus the clearance of nicotinamide (a product of the Sir2p deacetylase
reaction) which can inhibit the enzymatic action of Sir2p.

Figure 2.2. Northern analysis of NAD+ biosynthesis pathway genes in wild-type vs. rpd3Δ
cells. NAD+ pathway genes identified in the genetic screen were analyzed for differential gene
expression based on Sir2p dependence on NAD+ for its proper function. Probes generated for
mRNAs of QNS1, PNC1, and NPT1 showed no reproducible qualitative difference in gene
expression in wild-type vs. rpd3Δ cells. Actin (ACT1) was used as an input control.
As shown in the Northern blot analysis (Figure 2.2), the mRNA expression of the genes
QNS1, PNC1, and NPT1 showed no reproducible difference between wild-type (DDY 3 and 4)
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and rpd3Δ (DDY 3018 and 3021) strains even after three replications of the Northern
experiment. The Northern assay was also repeated in three replicates using different rpd3Δ
laboratory strains, DDY 1671 and 1677, and no difference in expression was noted between WT
and rpd3Δ. These consistent null results were also seen in Northern analyses of the genes NMA1,
NMA2, QPT1 (involved in the NAD+ de novo pathway), and TNA1 (involved in the NAD+
salvage pathway – nicotinic acid plasma membrane permease) (data not shown). The expression
of ACT1 (Actin) was used as an input (loading) control for all Northern analyses. The five
remaining genes identified in the genetic screen were knocked out and subjected to genetic,
phenotypic, and complementation analysis.
Genomic Knockouts of BRE1, BRE2, GDH2, GAT3, and RXT3 and rpd3Δ Cross Analysis
The original UV-mutated strains (white colonies) which contained random mutations in
potential effector genes may or may not have had a complete loss-of-function. Such mutations
can result in partially truncated proteins with a range of lower-end activity and high turnover
rates, but not necessarily a complete loss-of-function. To verify that the five remaining genes
were bona-fide effectors, the complete ORFs of each gene were individually knocked out and
replaced with a LEU2 gene marker. This complete knockout of the coding sequence would
insure that there was a complete loss-of-function of the potential effector genes. The analysis
was to assess if each individual gene knockout, when crossed to an rpd3Δ strain, would derepress
expression of the ADE2 gene and result in a colony color phenotype from red (rpd3Δ) to white
(rpd3ΔmutX).
As exemplified in Figure 2.3, the question remains if the potential effector is directly
involved in contributing to the integrity of the tRNA barrier element or if the effects are indirect
and results in a gradual loss of silencing before reaching the ADE2 gene. The five separate gene
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knockouts were generated through transformation of linear double-stranded DNA containing a
functional LEU2 gene and regions of homology to the target loci on both the 5’ and 3’ ends of
the DNA duplex into strain DDY 3161.

Figure 2.3. Schematic representation of the HMR region, tRNA barrier element and
inserted ADE2 gene. rpd3Δ strains enhance silencing from HMR downstream to the ADE2 gene.
Our hypothesis states that mutating (or deleting) a potential effector gene in the rpd3Δ
background will abolish the spread of silencing in the double mutant and the ADE2 gene will be
expressed. Whether or not the effector contributes to the integrity of the barrier element or
influences the robustness of silencing remains to be answered.
The oligonucleotides used for amplifying the LEU2 gene for each knockout were as follows:
BRE1 (912/913), GDH2 (916/917), BRE2 (925/926), GAT3 (929/930), and RXT3 (933/934). The
PCR-amplified linear DNA was transformed using high efficiency transformation (see Methods).
Gene integrations of LEU2 for the BRE1 locus and the RXT3 locus were verified by upstream
and downstream PCR. BRE2, GAT3, and GDH2 were verified by Southern blotting. Each newly
created strain carrying one knock out each of the five genes assayed (BRE1, BRE2, GAT3, RXT3,
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and GDH2) were subsequently crossed to an rpd3Δ (DDY 3155) strain and analyzed for colony
color phenotype change in the double mutants.

Figure 2.4. BRE1 and BRE2 are effectors of the rpd3Δ silencing effect. Knockouts of either
BRE1 or BRE2 in an rpd3Δ background halted the spread of silencing past the tRNA barrier to
the downstream inserted ADE2 gene. The colony color phenotype was reverted from a dark red
colony color in the rpd3Δ strain to a white colony color in both the bre1Δrpd3Δ and
bre2Δrpd3Δ strains.
Of the five strains assayed with individual genes deleted, only strains containing mutated
BRE1 or BRE2, when crossed with an rpd3Δ strain, showed a significant change in colony color
phenotype from red to white, thus abolishing the enhanced silencing effect of rpd3Δ at HMR
(Figure 2.4). The individual gene knockouts of GDH2, GAT3, and RXT3 all exhibited no
phenotype change (red to white) when crossed to the rpd3Δ background indicating that UV
mutagenesis did not produce a complete loss-of-function in these three genes. The bre1Δrpd3Δ
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and bre2Δrpd3Δ phenotype change was verified in complementation assays by transforming the
plasmids containing the BRE1 and BRE2 coding sequences back into the double knockout strains
bre1Δrpd3Δ and bre2Δrpd3Δ, respectively. The plasmids used for complementation were the
original plasmids obtained from the genomic library that contained the BRE1 and BRE2 ORFs in
the ~10 kb insert. Since the original library plasmids contained more than one potential ORF
(e.g. some library inserts contained both BRE2 and GAT3), we had to verify that BRE1 and BRE2
were the only genes (coding sequences) responsible for complementation of the rpd3∆ silencing
effect. We separately transformed laboratory-generated cloned plasmids containing the coding
sequence of wild-type BRE1 and BRE2 which were generated by gap repair techniques (see
Methods – Gene Knockouts) from wild-type strains. The individual bre1∆ or bre2∆ knockout
strains (no rpd3Δ background) created did not have any effect on the colony color phenotype
compared to WT (all white) which establishes bre1Δ and bre2Δ epistatic to rpd3Δ in a regulatory
pathway.
When analyzing enhanced silencing at the telomeres with WT, rpd3Δ, and our generated
knockout strains, including the double mutants, we took advantage of an inserted URA3 at the
telomeres for a growth marker and assayed for degrees of growth or non-growth on both YMD
minus uracil and 5-FOA+all mix. Silencing at the telomere on chromosome VII-L showed nearly
the same consistency of silencing as seen at the HMR region between WT and rpd3Δ strains. In
WT cells, there was growth on minus uracil but no growth on 5-FOA. In rpd3Δ strains, there was
no growth on minus uracil but growth on 5-FOA due to silencing of the URA3 gene at the
telomere (Table 2.3). The bre1Δ mutant grew slightly more on 5-FOA+all mix compared to WT
and showed less growth on minus uracil compared to WT indicating that BRE1 is potentially
contributing to silencing at the telomeres. The rpd3Δ strain showed an expected extended
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silencing at the telomeres with no growth on minus uracil and full growth on 5-FOA+all mix.
The bre1Δrpd3Δ double mutant rescued partial growth on minus uracil, while there was full
growth on 5-FOA+ all mix, suggesting partial de-repression of telomeric silencing.
Table 2.3. Phenotypic analysis of silencing at telomere region (URA3) on chromosome VII-L.

HMR and telomeric silencing was assessed through phenotypical analysis of colony color in three
separate isolates grown on YMD 15% adenine (HMR), YMD -ura (telomere), and growth on 5FOA+all (telomere). Colony color on 15% adenine – white (ADE2 expressed) or pink (ADE2
repressed), - no growth, +very little growth, ++spotty growth, +++more growth, ++++full growth
The bre2Δrpd3Δ double mutant had very little growth on minus uracil similar to rpd3Δ and full
growth on 5-FOA+all, suggesting a very weak de-repression of telomeric silencing. The bre2Δ
mutant showed very little growth on minus uracil and the growth on 5-FOA+all was similar to its
double mutant of bre2Δrpd3Δ. These results indicate that the mutants, bre1Δ and bre2Δ in the
rpd3Δ background, do not halt the spread of silencing at telomeres to the extent the same
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mutations do at HMR. Interestingly, based on these initial results, BRE1 may play a role in
silencing at the telomeres, while BRE2 seems to have no significant effect.
ChIP (Chromatin Immunoprecipitation) of H3K4me3 at HMR in WT vs. rpd3Δ
BRE1 encodes the E3 ubiquitin ligase for Rad6p (E2), which in an E2-E3 complex together
is recruited to promoter regions and ubiquitylates histone H2B on K123. This ubiquitylation is
required for the subsequent trimethylation of histone H3K4 by Set1p and H3K79 by Dot1p.
Set1p is the catalytic subunit of the COMPASS complex which mono-, di-, or tri-methylates
H3K4. Trimethylation of H3K4 is normally associated with active transcription, particularly in
the coding regions of genes (Bernstein, Humphrey et al. 2002; Santos-Rosa, Schneider et al.
2002). BRE2 encodes a functional subunit of the COMPASS (Set1p) complex. Since both BRE1
and BRE2 are either directly or indirectly involved in the trimethylation of H3K4 and H3K79, we
hypothesized that there might exist a qualitative difference in the trimethylation status of H3K4
at the HMR region and downstream loci through to the ADE2 gene in strains of WT, rpd3∆, and
the double mutants, bre1∆rpd3∆ and bre2∆rpd3∆.
We have already shown that the silencing effect of rpd3Δ at HMR is abolished in both the
double mutants of bre1Δrpd3Δ and bre2Δrpd3Δ. If BRE1 or BRE2 have a direct effect on the
methylation status of the underlying chromatin as effectors, we hypothesize that there would be
reduced enrichment of trimethylated H3K4 (H3K4me3) in the silenced regions downstream of
the tRNA barrier element in rpd3Δ strains and higher enrichment of H3K4me3 at these same
regions in both the WT and double mutant strains of bre1Δrpd3Δ and bre2Δrpd3Δ. We
performed chromatin immunoprecipitation (ChIP) using an antibody specific for H3K4me3 to
immunoprecipitate regions of HMR and downstream loci enriched in H3K4me3 (Figure 2.5).
The PCR primer sets used to amplify enriched regions include four regions in and between the
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two silencer sequences, E and I (A-D), the tRNA barrier element (E), and three regions in the
inserted downstream ADE2 gene (F-H).

Figure 2.5. ChIP (chromatin immunoprecipitation) of targeted H3K4me3 along the HMR
and downstream loci in wild-type vs. rpd3Δ cells. Schematic representation of the HMR region
with oligo primer sets labeled A through H at the regions where immunoprecipitated H3K4me3
cross-linked to DNA was PCR amplified. Shown below the schematic are the qualitative
enrichment levels of PCR-amplified regions A through H in WT and rpd3Δ strains tested. Also
included is a no antibody control (No Ab) which shows levels of non-specific background
enrichment and an input control for loaded DNA quantities.
As shown in Figure 2.5, there was no significant (or reproducible) difference in the enrichment
of H3K4me3 across the HMR and downstream region in WT vs. rpd3Δ cells. In fact, qualitative
enrichment levels appear to be almost identical in all regions assayed between the two strains,
with regions B, D, and E (Intra-HMR, I silencer, and tRNA gene) possibly showing slightly less
enrichment than the other sites in both strains (although Input Control for B and D also shows
less enrichment). We also followed up these ChIP experiments by assaying the enrichment of
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H3K4me3 in the double mutants of bre1∆rpd3∆ (DDY 3790) and bre2∆rpd3∆ (DDY 3918)
using the same PCR amplified regions comparing rpd3Δ and WT (data not shown). There was
also no reproducible difference in the trimethylation status of the entire HMR region using the
same primer sets A through H in both double mutants. Consistent with these null ChIP results
was the lack of consistent levels of immunoprecipitated H3K4me3 protein from Western blot
experiments in WT, rpd3∆, and both double mutant strains tested.
COS7 is a protein of undefined function but is a member of the DUP380 subfamily of
conserved, often subtelomerically-encoded proteins; the authentic, non-tagged protein is detected
in highly purified mitochondria in high-throughput studies (Spode, Maiwald et al. 2002). The
COS7 gene was previously used by Kirmizis et al. (2007) as a positive control in ChIP assays for
5’ enrichment of H3K4me3 levels (Kirmizis, Santos-Rosa et al. 2007). We employed the same
strategy and unlike this published report, our results showed equilavent levels in enrichment of
H3K4me3 at both the 5’ and 3’ ends of COS7 (whereas trimethylation enrichment is reported as
progressively decreasing from the 5’ to the 3’ end of the ORF). These results, along with the
acquisition of newer evidence on the mechanisms of silencing at telomeres involving the redistribution of Sir proteins, (Santos-Rosa, Bannister et al. 2004; Venkatasubrahmanyam, Hwang
et al. 2007; Ehrentraut, Weber et al. 2010), have prompted us to refine both our model and
hypothesis of the mechanism by which enhanced silencing occurs at HMR in rpd3Δ cells. Our
adjusted hypothesis also reflects the role that BRE1 and BRE2 play in the establishment of
extended silencing (methylation).
DISCUSSION
Previous results in our laboratory showed an enhanced silencing effect at HMR in rpd3Δ
strains, which bypassed the downstream tRNA barrier element. A novel bromodomain

65

containing gene, YTA7, was also shown to be required for restricting the propagation of silencing
independent of the tRNA barrier element (Jambunathan, Martinez et al. 2005). These results
implicate other factors can be involved in abolishing the spreading of heterochromatin such as
other bromodomain-containing proteins, along with factors involved in the proper functioning of
barriers. Alternatively, there are potential factors besides the ubiquitous Sir proteins involved in
the establishment, propagation, and maintenance of the increased silencing effect at HM,
telomeres, and ribosomal DNA loci in the rpd3Δ background. Using a genetic screen involving
UV-mutated rpd3Δ yeast strains, our results identified two effectors of the rpd3Δ silencing effect
that are essential for the extended spreading of heterochromatin which bypasses or spreads
through the tRNA barrier element at HMRa. These two effectors were identified as BRE1 and
BRE2. BRE1 encodes an E3 ubiquitin ligase for Rad6p and exists as a complex between the two,
where the heterocomplex is recruited to promoter regions and is responsible for the
ubiquitylation of H2BK123. This ubiquitylation of H2BK123 is required for the subsequent
trimethylation of H3K4 by the COMPASS complex and trimethylation of H3K79 by Dot1p.
Because of the direct methylation function of both these genes, it was of interest to analyze this
histone modification status of the HMR region.
Although we took advantage of the inserted URA3 gene on chromosome VII-L near the
telomere to assess silencing at telomeric ends, our main focus was to identify potential effectors
of heterochromatic silencing at HMR, since the goal and the focus of our studies was to elucidate
the mechanisms involved in the enhanced spread of silencing past the tRNA barrier element.
Based on the limited amount of preliminary data generated from growth assays that depend on a
marker gene at a telomere, there appears to be effects on silencing occurring at telomeres
mediated by BRE1.
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Strains deleted for RPD3 not only exhibit enhanced silencing at HM loci, telomeres, and
rDNA, but they also have a sporulation defect in homozygous diploid strains (rpd3Δ/rpd3Δ). To
determine if BRE1 or BRE2 contributed to this defect, we attempted to sporulate the homozygous
diploids rpd3Δbre1Δ/rpd3Δbre1Δ and rpd3Δbre2Δ/rpd3Δbre2Δ on carbon source-limiting
nitrogen-rich nutrient media and observe if these double mutant strains would correct the
sporulation defect that occurs in the homozygous rpd3Δ/rpd3 strains. Both diploid double
mutants showed no change of function in the sporulation/meiosis defect in rpd3Δ strains. After
3-4 days on nutrient limiting media at 30C and using light microscopy, we saw no formation of
sporulated tetrads from the diploids on YPD media. Another phenotype of an rpd3Δ strain is its
sensitivity to ethidium bromide during cell growth and mitosis. Neither of the double mutants
showed a decrease in growth sensitivity to ethidium bromide (growth on ethidium bromidesupplemented YPD was not enhanced in the double mutants) compared to WT.
The results we obtained in our ChIP assays were surprising since previous studies of the
COS7 gene have shown that there are progressive differences in H3K4me3 enrichment between
promoter and coding regions with a gradual decline of H3K4me3 levels from the 5’ to the 3’ end
(Kirmizis, Santos-Rosa et al. 2007). Another gene, PPH3, encodes the catalytic subunit of an
evolutionarily conserved protein phosphatase complex containing Psy2p and the regulatory
subunit Psy4p. PPH3 is required for cisplatin resistance and is involved in the activation of
Gln3p (Hoffmann, Jung et al. 1994). PPH3 is a constitutively active gene positively regulated by
the trimethylation of H3K4 by Set1p and has been employed as a positive control in previous
ChIP studies using antibodies specific for H3K4me3 (Santos-Rosa, Schneider et al. 2002). Our
ChIP assays at the genomic locus of PPH3 also resulted in equivalent enrichments of H3K4me3
contrary to previously reported results.
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These inconsistent and/or irreproducible ChIP results throughout the entire study shed doubt
on the quality of the polyclonal H3K4me3 antibody (AbCam #ab8580). The antibody used was
reportedly tested by the manufacturer with a blocking assay where the antibody detects a 17 kDa
band on a Western blot which is completely blocked by the addition of histone H3K4me3
peptide. Partial blocking was also observed with addition of histone H3K4me2 peptide
(http://www.abcam.com/Histone-H3-tri-methyl-K4-antibody-ChIP-Grade-ab8580.html).

The

specificity of the antibody used in our assays was not tested by the manufacturer in vivo, and our
results may reflect differences in binding of the antibody by short peptides versus the native
histone H3 protein.
The elusive mechanism of enhanced silencing in rpd3Δ strains at HM, telomeres, and rDNA
have perplexed researchers for over fifteen years. With the growing complexity of the ‘histone
code’ hypothesis, many studies have tried to elucidate the mechanism of silencing by the pattern
of histone modifications using genome-wide high-throughput ChIP-CHIP based assays. Research
on chromatin has also delved into the degree of chromatin-associated proteins or other factors
that directly bind to chromatin along with the specific modifications on particular amino acid
residues on histone proteins. More recent studies have looked to how indirect effects can
possibly play a role in the establishment or disruption of silencing heterochromatin. Our adjusted
hypothesis includes the supposition of indirect effects on how BRE1 and BRE2 contribute to
establishing the extended silencing in rpd3Δ strains. Chapter four of this dissertation will further
expand on our modified hypothesis and concomitant strategy in future experimental design and
execution, while at the same time taking into consideration the results of new studies, which
report intriguing evidence of indirect mechanisms to these silencing effects.
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Table 2.4. Strains of S. cerevisiae used in this study:
Strain

Genotype

DDY(Table 2.1.)

MATα ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rpd3Δ::KanMX

DDY 2

MATα/MATa ade2/ADE2 his3/his3 leu2/leu2 LYS2/lys2Δ trp1/trp1 ura3/ura3

DDY 3

MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 ^GAL can1-100

DDY 4

MATα ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 ^GAL can1-100

DDY 19

MATα his4

DDY 20

MATa his4

DDY 1671

MATα ADE2 his3 leu2 lys2Δ trp1 ura3 rpd3Δ::LEU2

DDY 1677

MATa ADE2 his3 leu2 lys2Δ trp1 ura3 rpd3Δ::LEU2

DDY 3018

MATα ADE2 his3 leu2 lys2 trp1 ura3 rpd3Δ::KanMX HMR wild type

DDY 3136

MATα ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2

DDY 3155

MATα ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rpd3Δ::KanMX

DDY 3021

MATa ADE2 his3 leu2 lys2 trp1 ura3 rpd3Δ::KanMX HMR wild type

DDY 3133

MATα ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rpd3Δ::KanMX

DDY 3160

MATα ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2

DDY 3161

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2

DDY 3162

MATa ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rpd3Δ::KanMX

DDY 3408

MATα ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rpd3Δ::KanMX

DDY 3690

MATα ade2 his3 leu2 LYS2 trp1 ura3 HMR-tRNA+19-ADE2 BRF1:3X FLAG:KanMX sir4Δ::LEU2

DDY 3761-3763

MATa ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 bre1Δ::LEU2

DDY 3764-3766

MATa ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 gdh2Δ::LEU2

DDY 3767-3769

MATa ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rxt3Δ::LEU2

DDY 3790

MATα ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 rpd3Δ::Kan MX bre1Δ::LEU2

DDY 3825

MATα ade2 his3 leu2 lys2 trp1 ura3 bre2Δ::LEU2

DDY 3846

MATa ade2 his3 leu2 LYS2 trp1 ura3 VII-L-URA3-TEL ppr1Δ::TRP1 HMR-ADE2 gat3Δ::LEU2

DDY 3847

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 bre2Δ::LEU2

DDY 3848

MATα ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 bre2Δ::LEU2

DDY 3854

MATa ade2 his3 leu2 lys2 trp1 ura3 HMR-ADE2 bre2Δ::LEU2

DDY 3855

MATα ade2 his3 leu2 lys2 trp1 ura3 HMR-ADE2 bre2Δ::LEU2

DDY 3878-3880

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 bre2Δ::LEU2 ppr1Δ::TRP1

DDY 3881-3884

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 ppr1Δ::TRP1 bre1Δ

DDY 3918

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 ppr1Δ::TRP1 bre2Δ::LEU2 rpd3Δ::KanMX

DDY 3970-3973

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 ppr1Δ::TRP1 bre2Δ

DDY 3984-3986

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 ppr1Δ::TRP1 bre1Δ

DDY 3987-3989

MATa ade2 his3 leu2 lys2 trp1 ura3 VII-L-URA3-TEL HMR-ADE2 ppr1Δ::TRP1 bre2Δ
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CHAPTER THREE
AUTOREGULATION OF AN RNA POLYMERASE II PROMOTER BY THE RNA
POLYMERASE III TRANSCRIPTION FACTOR III C (TFIIIC) COMPLEX *
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INTRODUCTION
The eukaryotic RNA polymerase III (Pol III) system is responsible for synthesizing transfer
RNA molecules and other transcripts, which in yeast include the U6 spliceosomal RNA, the 7SL
RNA, the 5S ribosomal RNA, the snr52 snoRNA, and the RNA component of RNaseP (Paule
and White 2000; Geiduschek and Kassavetis 2001; Huang and Maraia 2001). Transcription by
Pol III requires the activity of the multi-subunit transcription factor complex TFIIIC, which binds
to conserved A-box and B-box Pol III promoter elements, and functions to overcome chromatin
repression of Pol III transcription and to recruit the TFIIIB complex (Burnol, Margottin et al.
1993; Kundu, Wang et al. 1999; Geiduschek and Kassavetis 2001). While Pol III and its
transcription factors are thought to be dedicated to transcription of these specific genes, a
growing body of evidence has shown that both partial and complete chromosomally bound Pol
III complexes can have effects on RNA Polymerase II (Pol II) promoters (Donze and Kamakaka
2001; Simms, Miller et al. 2004; Noma, Cam et al. 2006; Scott, White et al. 2007; Simms, Dugas
et al. 2008). Chromatin bound Pol III complexes also mediate other extra-transcriptional
functions including targeting Ty element integration (Chalker and Sandmeyer 1992; Kirchner,
Connolly et al. 1995; Devine and Boeke 1996), blocking of replication fork progression
(Deshpande and Newlon 1996), condensin and cohesin recruitment (Dubey and Gartenberg
2007; Haeusler, Pratt-Hyatt et al. 2008), and direct inhibition of transcription from nearby Pol II
promoters (Kinsey and Sandmeyer 1991; Hull, Erickson et al. 1994; Bolton and Boeke 2003;
Simms, Miller et al. 2004).
Studies in both budding and fission yeast initially identified the presence of genome
sequences that bind the TFIIIC complex, but not the other Pol III transcription factors TFIIIA,
TFIIIB, or the Pol III enzymatic complex itself (Harismendy, Gendrel et al. 2003; Roberts,
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Stewart et al. 2003; Moqtaderi and Struhl 2004; Noma, Cam et al. 2006). Recently, similar sites
have been identified in human cells (Canella, Praz et al. 2010; Moqtaderi, Wang et al. 2010;
Oler, Alla et al. 2010; Raha, Wang et al. 2010). These B-box containing sequences are referred
to either as ETC (Extra TFIIIC) or TFIIIC-only sites in budding yeast, and COCs (Chromatin
Organizing Clamps) in fission yeast (Roberts, Stewart et al. 2003; Moqtaderi and Struhl 2004;
Noma, Cam et al. 2006). Particular TFIIIC binding sites have been shown to function as
chromatin boundary elements (Noma, Cam et al. 2006; Simms, Dugas et al. 2008), but the
genome-wide function of the TFIIIC bound ETC sites remains unknown.
Interestingly, one ETC site in Saccharomyces cerevisiae, ETC6, lies within the promoter of
the TFC6 gene, which encodes a subunit of the TFIIIC complex itself. We hypothesized that the
Tfc6 protein, as part of the TFIIIC complex, might autoregulate its own promoter by binding to
ETC6 and function as an insulator. Autoregulation of gene expression is critically important in
all forms of life, from its role in the lysogen/lytic growth decision of bacteriophage λ (Ptashne
2005), to having important roles in developmental and neuronal gene expression in metazoans
(Crews and Pearson 2009; Hobert 2011). Our results identify the B-box within ETC6 as a
functional regulatory element within the TFC6 promoter that mediates stringent autoregulation
of the promoter; this regulation is sensitive to Tfc6 protein levels and binding of the TF IIIC
complex. This appears to be the first demonstration of a core Pol III transcription factor complex
directly regulating the transcription of a Pol II promoter, and this tight regulation of Tfc6p levels
could be important in regulating global tRNA expression, which could have subsequent global
effects on translational regulation. Our results also implicate a potential UAS immediately
upstream of ETC6 that potentially binds an activating transcription factor which gives us clues to
the mechanism of TFC6 gene activation/regulation and TFIIIC’s role as an insulator.
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MATERIALS AND METHODS
5’RACE analysis was performed using the First Choice RLM-RACE kit (Ambion-Applied
Biosystems #AM1700). Construction of the promoter mutants is described in the legend to
Figure 3.1. Each mutant intergenic region was re-integrated into chromosome IV by
transformation into strain DDY3453 (etc6Δ::URA3) and selection on 5-FOA media, and were
verified by PCR of genomic DNA, and digestion of the PCR products with Drd I to verify the
presence of the mutation. DDY3453 was created by standard yeast knockout techniques using
oligonucleotides DDO-792 and 793 to amplify URA3 from plasmid pRS406 (Sikorski and Hieter
1989). All oligonucleotide sequences are listed in Table 3.2. Northern blot analyses were
performed as described in Chapter Two (Methods).
Plasmids expressing TFIIIC subunits Tfc1p, Tfc3p, and Tfc6p were constructed by PCR
amplification of each gene plus approximately 500 base pairs upstream and downstream from
yeast genomic DNA using the high fidelity Phusion DNA polymerase (New England Biolabs, F530S). Functional expression was verified by complementation of mutant strains. TFC4 was
subcloned from a previously characterized plasmid PCF1 (kindly provided by Ian Willis). Each
gene was cloned into the HIS3 marked pRS series of ARS-CEN and 2μ vectors (Sikorski and
Hieter 1989; Kurdistani and Grunstein 2003).
Chromatin immunoprecipitation (ChIP) was performed as described in Chapter Two
(Methods), using the TFC1-3X-FLAG allele crossed into the appropriate strains. Anti-FLAG
monoclonal M2 was from Sigma (F1804), and anti-yeast TBP from Santa Cruz Biotechnology
(sc-33736). Quantitation of ChIP signals was determined by radioactive PCR according to
(Kurdistani and Grunstein 2003), except that samples were resolved on 1.2% agarose gels. ChIP
signals were normalized to the background PCR signal generated using primers homologous to
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the non-TFIIIC binding GAL1-10 intergenic region (oligos DDO1023 and 1024) to control for
background and sample variation. All quantitative ChIP results were averaged from three
independent determinations.
TFC6 promoter-URA3 ORF reporter strains were constructed by standard yeast
recombination methods, using oligonucleotides DDO-1201 and DDO-1202 homologous to the
ends of the URA3 open reading frame plus 50 bases immediately upstream and downstream of
the TFC6 open reading frame to amplify the coding sequence of URA3. Ura+ recombinants
expressing URA3 from the TFC6 promoter were slow growing on media lacking uracil (required
4-5 days to appear) and were slightly temperature sensitive; therefore all colony growth
experiments were performed at 25ºC. To compare colony sizes, tfc6Δ::URA3 cells were
transformed with empty pRS vector (Sikorski and Hieter 1989; Christianson, Sikorski et al.
1992) or HIS3 marked TFIIIC subunit expressing plasmids and plated on minimal media lacking
histidine. His+ isolates were grown in liquid media lacking histidine and plated at ~50
colonies/plate on media lacking histidine, and media lacking both histidine and uracil. Plates
were incubated at 25ºC for three days (minus histidine) or five to six days (minus histidine and
uracil) before photographing. Relative colony sizes from 30-50 colonies were measured and
analyzed using ImageJ software (http://rsbweb.nih.gov/ij/).
Table 3.1. Plasmids used and/or generated in this study:
Plasmid

Reference/Source

pRS406 URA3 vector
pRS413 ARS-CEN HIS3 vector
pRS423 2μ HIS3 vector
pDD1098 TFC6-ESC2 intergenic region (~640 bp) in Bluescript SK+
pDD1179 TFC6 in pRS413, ARS-CEN HIS3
pDD1184 TFC6 promoter mutant #1
pDD1185 TFC6 promoter mutant #2
pDD1186 TFC6 promoter mutant #3
pDD1187 TFC6 promoter mutant #4
pDD1188 TFC6 promoter mutant #5
pDD1189 TFC6 promoter mutant #6

(Sikorski and Hieter 1989)
(Sikorski and Hieter 1989)
(Christianson, Sikorski et al. 1992)
(Simms, Dugas et al. 2008)
This study
This study
This study
This study
This study
This study
This study

(Table 3.1 Continued)
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pDD1190 TFC6 promoter mutant #7
pDD1197 TFC6 in pRS423, 2μ HIS3
pDD1226 TFC1 in pRS423, 2μ HIS3
pDD1228 TFC3 in pRS423, 2μ HIS3
pDD1234 ADH1 promoter-TFC6 in pRS413, ARS-CEN HIS3
pDD1244 TFC6-FLAG in pRS423, 2μ HIS3
pDD1245 TFC6-FLAG in pRS413, ARS-CEN HIS3

This study
This study
This study
This study
This study
This study
This study

Table 3.2. Oligos used in this study:
Oligo

Sequence

TFC6 promoter mutagenesis – bases in red correspond to the Drd I site as described in the methods
DDO-1135 CATTTCTTTTCTTATATGCTACAATGACCGGGTAGTCCTTCTGTAAGGAAATAGAAGG
TFC6 PROMOTER MUTANT #1 top
DDO-1136 CCTTCTATTTCCTTACAGAAGGACTACCCGGTCATTGTAGCATATAAGAAAAGAAATG
TFC6 PROMOTER MUTANT #1 bottom
DDO-1137 GCTACAATAAAATTTGCTGTCGACGTGCCTGTCATAGAAGGGATTCAGTATCACC
TFC6 PROMOTER MUTANT #2 top
DDO-1138 GGTGATACTGAATCCCTTCTATGACAGGCACGTCGACAGCAAATTTTATTGTAGC
TFC6 PROMOTER MUTANT #2 bottom
DDO-1139 GTAAGGAAATAGAAGGGATTCAGGACACAAATGTCAGCTGCGGTTCGAAAACCCTAC
TFC6 PROMOTER MUTANT #3 top
DDO-1140 GTAGGGTTTTCGAACCGCAGCTGACATTTGTGTCCTGAATCCCTTCTATTTCCTTAC
TFC6 PROMOTER MUTANT #3 bottom
DDO-1141 GGATTCAGTATCACCCGGAAGACGTATTGGTCAAAACCCTACGTTGCAAAAGAAG
TFC6 PROMOTER MUTANT #4 top
DDO-1142 CTTCTTTTGCAACGTAGGGTTTTGACCAATACGTCTTCCGGGTGATACTGAATCC
TFC6 PROMOTER MUTANT #4 bottom
DDO-1143 CACCCGGAAAGCTGCGGTTCGGACCAAAGCGTCTGCAAAAGAAGATAAACAACATTC
TFC6 PROMOTER MUTANT #5 top
DDO-1144 GAATGTTGTTTATCTTCTTTTGCAGACGCTTTGGTCCGAACCGCAGCTTTCCGGGTG
TFC6 PROMOTER MUTANT #5 bottom
DDO-1145 CGGTTCGAAAACCCTACGTGACCCCCTCGTCTAAACAACATTCCATTTTTTGTTCG
TFC6 PROMOTER MUTANT #6 top
DDO-1146 CGAACAAAAAATGGAATGTTGTTTAGACGAGGGGGTCACGTAGGGTTTTCGAACCG
TFC6 PROMOTER MUTANT #6 bottom
DDO-1147 GCAAAAGAAGATAAACAACATTCCGACTTTTGTGTCAGAAAGCCTGGATGAGTTG
TFC6 PROMOTER MUTANT #7 top
DDO-1148 CAACTCATCCAGGCTTTCTGACACAAAAGTCGGAATGTTGTTTATCTTCTTTTGC
TFC6 PROMOTER MUTANT #7 bottom
Chromatin IP
DDO-305 CGTGCCGGTGAAACATATATGTCT
Chromosome XVI tF(GAA)P2 ChIP top
DDO-306 CAAGTTCAAGAACCAACTTTCCGC
Chromosome XVI tF(GAA)P2 ChIP bottom
DDO-307 GCACTAGTTGATTCTTGTTCCAACAG
Chromosome VII tK(CUU)G1 ChIP top
DDO-308 CCGTTTTTCCCCAGAGCACTTTTA
Chromosome VII tK(CUU)G1 ChIP bottom
DDO-705 ATTATTACACGTATCGCAATGG
ETC6 ChIP top
DDO-1093 CTTCTGGAATCACCGGTCATC
ETC6 ChIP bottom
DDO-1023 CCATATACATATCCATATCTAATC
GAL LOCUS ChIP top
DDO-1024 ATAACCATAAAAGCTAGTATTGTAG
GAL LOCUS ChIP bottom
DDO-1215 GCCATTCTCTTATCTTCCAAG
ETC4 ChIP top
DDO-698 AAGTAAGGTTTGCATATGCGG
ETC4 ChIP bottom
DDO-1343 GTCTTAGTTTGATTGAGCGACAAG
ETC5/RNA170 ChIP top
DDO-1344 AAACAAGGGTTGTGGAGTATGC
ETC5/RNA170 ChIP bottom
DDO-1345 TAGCAGTTTATGTACGCATTTTAAAAGC
ZOD1 ChIP top
DDO-1346 TGCTGTCTTATTCCCTAGTGTC
ZOD1 ChIP bottom
DDO-1402 TACGACATCAAAGTCGCCGAG
Chromosome XII tR(CCG)L CHIP TOP
DDO-1403 ATTGACAGCCCTTACGCGAAG
Chromosome XII tR(CCG)L CHIP bottom
Knockout and insertion – bases in green correspond to the pRS416 plasmid sequence adjacent
to URA3. Bases in red correspond to the start and end of the URA3 open reading frame.
DDO-792 CAACTCATCCAGGCTTTCTCGAACAAAAAATGGAATGTTGTTTATCTTCTTTTGCAGATTGTACTGAGAGTG
ETC6 delete URA3 KO TOP
DDO-793 ATTTGCTGTCTTCTGTAAGGAAATAGAAGGGATTCAGTATCACCCGGAAAGCTCTCCTTACGCATCTGTGCGG
ETC6 delete URA3 KO BOTTOM
DDO-1201 CTCTAACTTGCTCCATTGCGATACGTGTAATAATATATTAAGTTGTGGCGATGTCGAAAGCTACATATAAG
TFC6 del URA3 ORF top
DDO-1202 GTCAACAATAGTTCAATGTCACAAATTGTATTTATTACGTAAAGTCCATCTTAGTTTTGCTGGCCGCATC
TFC6 del URA3 ORF bottom

RESULTS
Inhibition of TFIIIC Binding to ETC6 Results in Increased TFC6 Transcript Levels.
We used a combined transcript mapping, bioinformatic and mutational approach to identify
the potential promoter elements upstream of TFC6. 5’-RACE analysis was performed to map
transcriptional start sites, which were identified at bases minus 46, 96, 98, 104, and 110 from the
annotated TFC6 translational start site (Figure 3.1).
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Figure 3.1. Comparison of the TFC6 promoter region among budding yeast species.
Sequences were aligned using Clustal software available through the Saccharomyces Genome
Database website. Shaded boxes covering regions of highest homology were designated as sites
1-7, and were mutated as described below; mutagenic oligonucleotides are listed in Table 3.2.
Transcription start sites marked in red were determined by 5’RACE analysis. The numbers above
each arrow refer to the location of the start site relative to the start codon (Met), and the numbers
in parentheses are the number of independent 5’RACE clones obtained for that start site. The
region of the ETC6 B-box is marked by the green shading.
Promoter mutants were constructed by site-directed mutagenesis of plasmid pDD1098 which
contains the TFC6-ESC2 intergenic region (from Saccharomyces Genome Database chromosome
IV coordinates 1198718 to 1199357, www.yeastgenome.org/, as of 20 October 2010) cloned into
Bluescript SK+. Each mutant had a 12 base pair region replaced with a Drd I restriction enzyme
site (Quik-Change kit, Stratagene), which allowed scrambling of 10-12 base pairs within each
region, and initial restriction digest screening of mutants, which were verified by DNA
sequencing.
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Mapping of the start sites allowed us to focus on the upstream region to identify promoter
elements. Comparison of the TFC6 promoter regions from five budding yeast species revealed
regions of high conservation in addition to the ETC6 site B-box sequence. Regions containing
six or more bases common to all five species over a twelve base stretch were designated as
promoter boxes 1-7, as shown schematically in Figure 3.2A and at sequence level detail in
Figure 3.1. These 12-base pair boxes were mutated on plasmids, re-integrated into the yeast
genome, and Northern blot analysis for TFC6 mRNA was performed for each mutant.
The results in Figure 3.2B show that the major effects were seen clustered across promoter
mutants 3, 4, and 5. Mutant 3 results in a significant decrease in TFC6 mRNA, and this mutant is
compromised for growth due to limiting TFC6 expression, as complementation with a TFC6
plasmid restores normal growth (Figure 3.3). Mutants 4 and 5, which both span the ETC6 site,
show a 2-fold increase in TFC6 mRNA levels, which is consistent with our previous results
mutating this site (Simms, Dugas et al. 2008). These results are also consistent with mutant 3
affecting a transcription factor binding site, and with the ETC6 site B-box being involved in
negative regulation of the TFC6 promoter.
To further test the hypothesis that TFIIIC binding to ETC6 is involved in TFC6 autoregulation, we performed TFC6 Northern blots on strains containing conditional mutations of the
RNA polymerase III machinery. The mutant tfc3-G349E is a temperature sensitive allele of a
TFIIIC component that reduces binding affinity (measured in vitro) of the TFIIIC complex for
tDNAs (Lefebvre, Ruth et al. 1994). Mutations brf1 II-9 and II-6 are impaired in Brf1p
interaction with TBP (Andrau, Sentenac et al. 1999); rpc31-236 is defective in Pol III initiation
(Thuillier, Stettler et al. 1995); and rpc160-112 is defective in elongation (Dieci, Hermann-Le
Denmat et al. 1995).
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Figure 3.2. Characterization of the S. cerevisiae TFC6 promoter suggests autoregulation by
the TFIIIC complex. A) Transcriptional start sites upstream of TFC6 were mapped by 5’- RACE
analysis, and are detailed in Figure 3.1. TFC6 promoter regions of highest homology among five
budding yeast species are designated promoter boxes 1-7, also detailed in Figure 3.1. B) Mutant
promoters were re-integrated into the yeast chromosome, and relative TFC6 mRNA levels
determined by Northern blotting. Expression was determined from three independently isolated
strains for each mutation; one each is shown here. C) Temperature sensitive mutation in TFC3,
but not other Pol III mutations result in increased TFC6 transcript levels. Strains containing
mutant alleles of TFIIIC, TFIIIB, and Pol III components were grown at permissive temperature
(30C), then pulsed for one hour at the non-permissive temperature (37C) before RNA extraction
and Northern analysis.
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Figure 3.3. TFC6 promoter mutant #3 exhibits a slow growth phenotype due to insufficient
TFC6 expression. Wild type (DDY3630) and promoter mutant #3 (DDY4301) strains were
transformed with either HIS3 vector (pRS413) or the same vector containing the TFC6 gene
(pDD1179), and streaked onto minimal media lacking histidine. The slow growth phenotype of
strain DDY4301 is complemented by the TFC6 expressing plasmid. Identical complementation
results were obtained using two independent promoter mutant #3 isolates, and also in strain
DDY4114 (described in Simms et al, 2008), which has the ETC6 site and the upstream region
deleted.
The results in Figure 3.2C demonstrate that only the tfc3-G349E mutant contained increased
TFC6 transcript levels. This is consistent with direct TFIIIC mediated regulation of TFC6
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transcription, and not a result of reduced Pol III activity, as the other mutations that globally
impair Pol III transcription had little effect on TFC6 mRNA levels.
Inverse Correlation of TFIIIC Association at ETC6 and TFC6 Transcript Levels.
To confirm that the mutant etc6 and tfc3 strains were indeed defective for in vivo binding of
TFIIIC to ETC6, we performed chromatin immunoprecipitation (ChIP) against a carboxyterminal 3XFLAG-epitope tagged Tfc1p subunit (Figure 3.4) in both tfc3-G349E and etc6 B-box
mutant strains. The B-box mutation changes a cytosine residue conserved in all TFIIIC binding
sites to a guanine, and is known to inhibit TFIIIC binding in vitro (Newman, Ogden et al. 1983).
The results shown in Figure 3.4A illustrate that both mutations lead to a loss of TFIIIC
association with the TFC6 promoter in vivo, and reduced binding correlates with the relative
increase in TFC6 transcript levels in the same mutants (Figure 3.4B).
Over-Expression of TFC6 Inhibits Expression From Its Own Promoter.
If Tfc6 protein levels are directly autoregulating its own promoter, then overexpression of
TFC6 from an episomal plasmid was predicted to reduce transcription from the endogenous
chromosomal promoter. In order to test this hypothesis, we created diploid yeast strains that have
the URA3 open reading frame precisely replacing one chromosomal copy of the TFC6 open
reading frame (Figure 3.5A). These strains allowed us to assess the level of TFC6 promoter
activity independent of episomal expression by assessing growth on media lacking uracil. TFC6
was overexpressed in strain DDY4520, both from its own promoter on a high-copy plasmid
containing the entire TFC6 gene, or from the ADH1 promoter on a low copy plasmid. Increased
TFC6 expression has no effect on growth of this strain on media lacking only histidine compared
to cells transformed with the HIS3 vector alone (Figure 3.5B), showing that increased Tfc6p
levels alone do not inhibit growth.
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Figure 3.4. TFIIIC binding to ETC6 is inversely correlated to TFC6 mRNA levels. A) Strains
containing 3X-FLAG-epitope tagged TFC1 and either tfc3-G349E or etc6 B-box mutant alleles
were constructed, chromatin extracts prepared for immunoprecipitation and relative TFIIIC
association at the TFC6 promoter determined. B) Reduction of TFIIIC binding by either mutation
is correlated to increased TFC6 mRNA levels.
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Figure 3.5. Overexpression of Tfc6p down-regulates gene expression driven by the TFC6
promoter, and increases the association of the TFIIIC complex to ETC6. A) Diploid strain
DDY4520 was constructed to contain the URA3 open reading frame (ORF) integrated in place of
the TFC6 ORF on one copy of chromosome IV to test the effects of episomal TFC6
overexpression. B) Vector controls, 2μ HIS3 TFC6, or ARS-CEN HIS3 ADH1- promoter-TFC6
plasmid transformants were plated on media lacking histidine or both histidine and uracil, and
colony sizes were measured after three days (minus histidine) or five days (minus histidine minus
uracil) at 25C. C) ChIP of TFC1-3X-FLAG strains transformed with vector or ADH1 promoterTFC6 plasmid show increased Tfc1p association, and decreased TBP at ETC6 when TFC6 is
overexpressed. Quantitative results were averaged from three separate determinations.
However, when the same cells were plated on minimal media lacking both histidine and uracil,
the average colony sizes formed by cells containing either the high-copy or ADH1-promoter
plasmid were consistently 65-70% of controls containing the empty vector. This effect is dose
dependent, as expression of TFC6 from its own promoter on a lower copy ARS-CEN plasmid
reduces average colony size to only 89% of controls (Figure 3.6 A & B). ChIP against TFC13XFLAG showed that overexpression of TFC6 resulted in increased association of TFIIIC at
ETC6 (Figure 3.5C), as the amount of TFC6 promoter DNA immunoprecipitated was ~1.7 times
the vector control. This correlated with a decrease in TATA binding protein (TBP) association at
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the TFC6 promoter, as the anti-TBP ChIP signal was only ~70% compared to the vector control
(Figure 3.5C). These results show that overexpression of TFC6 increases the degree of TFIIIC
association with ETC6, and reduces expression from its own promoter, presumably due to
increased stability of TFIIIC binding to the ETC6 site, leading to reduced TBP association.

Figure 3.6. Tfc6p inhibition of Its own promoter is dose dependent. A) Strain DDY4403
containing the TFC6 promoter driving URA3 was transformed with empty HIS3 vector, low
copy ARS-CEN-TFC6 plasmid, or high copy 2μ-TFC6 plasmid. Platings and colony size
determinations were as in Fig. 3.5 and as described in the methods. B) Bar graph represents the
measurement of at least 30 colonies from three separate images. C) Western blot analysis to
estimate the relative level of overexpression of TFC6. The same plasmids used in A and B were
modified to contain the identical triple FLAG epitope that is integrated as a single copy in the
haploid strain DDY4107 (pDD1244 = 2μ TFC6- 3XFLAG, pDD1245 = ARS-CEN TFC63XFLAG). DDY4107 was then transformed with either empty HIS3 vector (pRS413) to measure
normal Tfc6p levels, or each of the TFC6-FLAG plasmids. Total protein extracts from each
strain were prepared and equal protein amounts were immunoprecipitated with anti-FLAG M2
monoclonal antibody (Sigma), and the concentrated immunoprecipitates were analyzed by
Western blotting using the same antibody. Relative amounts were assessed by scanning the blot
on a Pharmacia Typhoon 8600 Phosphorimager on the chemiluminescent setting, and using
ImageQuant software to measure the relative signals.
Auto-Regulation of TFC6 is ETC6 Site B-Box Dependent and Tfc6p Specific.
If increased binding of TFIIIC to ETC6 is indeed responsible for reduced growth on media
lacking uracil, we predicted that a strain with URA3 driven by a TFC6 promoter containing the
defective B-box within ETC6 would be insensitive to overexpressed TFC6 when grown on
media lacking uracil.
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Figure 3.7. Downregulation of the TFC6 promoter by Tfc6p requires the ETC6 B-box and is
specific to TFC6 overexpression. A) Strain DDY4521 was constructed to contain a mutant Bbox linked in cis- to the TFC6 promoter driving URA3. TFC6 was overexpressed as in Fig. 3.6.,
and was unable to downregulate the TFC6 promoter containing the mutant B-box, as indicated by
no change in colony sizes. B) Overexpression of other TFIIIC subunits in DDY4403. High-copy
2µ plasmids encoding each gene driven by its native promoter were transformed into the URA3
reporter strain and plated on minimal media lacking histidine and uracil, and colony sizes relative
to the vector control were determined as in Fig. 3.6.
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Strain DDY4521 is identical to DDY4520 except for the presence of the cytosine to guanine
mutation in the ETC6 B-box upstream of the URA3 marker. The results in Figure 3.7A confirm
that the inhibition is mediated through the ETC site, as when TFC6 is overexpressed in the strain
containing the mutant B-box, no reduction of colony size is observed on media lacking uracil.
We next asked if overexpression of other TFIIIC subunits would affect URA3 expression
from the TFC6 promoter. Large-scale proteomic studies of yeast protein expression have
estimated the number of protein molecules per yeast cell (Ghaemmaghami, Huh et al. 2003), and
the results suggest that Tfc3p, Tfc4p, and Tfc6p are the most limiting components of the TFIIIC
complex. Tfc1p appears to be present in large excess, and Tfc7p and Tfc8p are at intermediate
levels. Indeed, this apparent excess of at least Tfc1p and Tfc7p was determined to exist as a
chromatographically separable sub-complex in yeast extracts (Manaud, Arrebola et al. 1998). We
confirmed that Tfc6p is limiting relative to Tfc1p, as Western blots of protein extracts from
strains containing the identical triple FLAG epitope on each gene show a large relative excess of
Tfc1p expression compared to Tfc6p (Figure 3.8.). We also determined by Western blotting that
Tfc1p levels are not significantly affected by the tfc3-G349E temperature sensitive mutation used
in this study (Figure 3.9.). These endogenous ratios suggest that overexpression of other limiting
subunits might also increase the level of TFIIIC complex binding to ETC6 and reduce TFC6
promoter activity, while overexpression of TFC1 should have no effect since it is already largely
in excess. 2µ plasmids containing TFC1, TFC3, TFC4, and TFC6 were separately transformed
into strain DDY4403 (TFC6 promoter-URA3, similar to DDY4520, but in the S288C
background) and plated on media lacking both histidine and uracil. Colony sizes were
determined at six days of growth, and the results are shown in Figure 3.7B. As expected, overexpression of TFC1 had no effect on cell growth, nor did overexpression of TFC4.
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Figure 3.8. Western blot analysis of yeast strains containing identical carboxy-terminal
triple-FLAG epitope tags on TFC1 (DDY4381), TFC6 (DDY4107), or BRF1 (DDY844).
Total protein extracts from each strain were prepared and equal protein amounts were
immunoprecipitated with anti-FLAG M2 monoclonal antibody (Sigma), and the concentrated
immunoprecipitates were analyzed by Western blotting using the same antibody. Tfc6 protein
levels are limiting compared to Tfc1p and Brf1p levels.

Figure 3.9. Tfc1p levels are not significantly affected by the tfc3-G349E temperature
sensitive mutation. Whole cell extracts from TFC1-3XFLAG strains were prepared and
equivalent protein amounts were immunoprecipitated with anti-FLAG antibody. The
immunoprecipitates were subjected to Western blot analysis with anti-FLAG primary antibody.
No significant difference was seen in the wild type versus tfc3-G349E mutant.
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Expression of TFC3 appeared to inhibit growth slightly, but not as much as TFC6. These results
demonstrate that the TFC6 promoter is preferentially sensitive to increased levels of its cognate
gene product.
Overexpression of TFC6 Results in Elevated TFIIIC Association at Multiple Loci.

Figure 3.10. Overexpression of TFC6 increases TFIIIC association at multiple genomic loci.
Strain DDY4381 (TFC1-3XFLAG) was transformed with either empty vector or pDD1234
(ADH1 promoter-TFC6) to overexpress Tfc6p. Binding of TFIIIC was assessed at several B-box
sites by ChIP using anti-FLAG antibody, each of which showed increased enrichment when
Tfc6p was overexpressed. As in Figure 3.5, determinations were performed in triplicate,
normalized to the GAL locus signal, and one pair of lanes is shown for each locus.
DISCUSSION
Since TFIIIC binding at ETC6 was increased upon overexpression of Tfc6p, we tested other
B-box containing loci by ChIP for enrichment of the TFIIIC complex. The results in Figure 3.10
demonstrate that all loci tested, which included three tDNAs, the ZOD1/UFO1 locus, and ETC4
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and ETC5, an increase in TFIIIC association was observed upon episomal expression of TFC6.
The magnitude of this increase varied from 1.2-fold to over 2-fold. Despite this seemingly
general increase in TFIIIC binding, we have not yet identified any tDNAs or other loci that show
altered levels of Pol III transcription (see discussion).
DISCUSSION
Although Pol III is dedicated to the transcription of tDNAs and a handful of other RNAs,
genome wide ChIP studies in yeast have demonstrated the presence of the transcription factor
complex TFIIIC at chromosomal locations not associated with the Pol III complex (Harismendy,
Gendrel et al. 2003; Roberts, Stewart et al. 2003; Moqtaderi and Struhl 2004; Noma, Cam et al.
2006). Recently, similar studies using human cells and high-throughput sequencing detection
(ChIP-Seq) have also demonstrated the presence of such sites beyond yeast (Canella, Praz et al.
2010; Moqtaderi, Wang et al. 2010; Oler, Alla et al. 2010; Raha, Wang et al. 2010). These loci
have been referred to as ETC (extra TFIIIC) sites, COC (chromatin organizing clamps), or TFIIIConly sites, and have been shown to affect expression of neighboring Pol II genes by acting as
chromatin boundary elements (Noma, Cam et al. 2006; Simms, Dugas et al. 2008). This study set
out to further characterize the role of the TFIIIC binding site ETC6 in S. cerevisiae, which lies in
the promoter of the TFC6 gene encoding a subunit of the TFIIIC complex itself. The location of
this site was noted by Moqtaderi and Struhl in their study characterizing ETC sites (Moqtaderi
and Struhl 2004), and they suggested the possibility that TFIIIC might regulate this promoter.
Our results confirm their speculation, as we show that ETC6 is a functional promoter
element of the TFC6 gene that mediates autoregulation of TFC6 expression in response to Tfc6
protein levels. We show that inhibition of TFIIIC binding to ETC6 results in increased TFC6
transcript levels, while overexpression of Tfc6p increases association of the TFIIIC complex at
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ETC6 and inhibits expression from the TFC6 promoter. These results suggest that Pol II
transcription of TFC6 is sensitive to the level of its own protein product, a product that is part of
what was previously thought to be a dedicated core Pol III transcription factor. While such
crosstalk between Pol II transcription factors and Pol III promoters has been described for the
Octamer binding proteins and the SNAPc complex in mammalian systems (Schramm and
Hernandez 2002), they appear to be general Pol II transcription factors that act on a limited
subset of Pol III promoters. Therefore, this does appear to be the first demonstration of a core Pol
III factor regulating Pol II transcription.
The results presented here also begs the question of how does the TFIIIC complex inhibit
expression from its own promoter. Data in Figure 3.5 show reduction in TBP association at the
TFC6 promoter when TFC6 is episomally overexpressed; while this may be due to direct
inhibition of TBP binding, this reduction might also be a consequence of other mechanisms. We
previously suggested (Simms, Dugas et al. 2008) that inhibition may occur via an insulator-like
mechanism, with bound TFIIIC inhibiting upstream transcription factors from recruiting a
productive pre-initiation complex at the transcription start site. However, since the key TFC6
promoter element (mutant site #3) is immediately upstream of the ETC6 B-box, we also consider
that TFIIIC and the putative transcription factor may be in competition for binding to the same
region of DNA.
While much work has been done on the global control of Pol III transcription by the Maf1
mediated pathway (Willis and Moir 2007; Ciesla and Boguta 2008; Goodfellow, Graham et al.
2008), few studies have looked at the role of the regulation of expression of the Pol III
transcription factors themselves. In yeast, over-expression of TFIIIB70 (Brf1p) elevates expression
of promoter mutant tDNAs (Sethy-Coraci, Moir et al. 1998). In mammalian cells, overexpression
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of Brf1 stimulates Pol III transcription, while shRNA inhibition of Brf1 expression reduces
oncogenic transformation and tumor formation in a mouse model (Johnson, Dubeau et al. 2008;
Marshall, Kenneth et al. 2008). These results indicate that levels of the Pol III transcription
factors can have critical roles in regulating Pol III transcription and cell proliferation.
Autoregulatory circuits have been identified as key components controlling gene
expression, and have evolved in organisms from bacteriophage to humans (Crews and Pearson
2009). Bacteriophage λ uses its CI repressor protein to both positively regulate its own
expression, and then negatively regulate itself when the cellular concentration of the protein
reaches proper levels, a key circuit in maintaining the inducible lysogenic state (Ptashne 2005).
Neuronal terminal differentiation genes in C. elegans are controlled by autoregulated terminal
selector transcription factors, and disruption of this process can lead to defective neuron function
(Hobert 2011); many other instances of autoregulation could be cited (Crews and Pearson 2009).
Given that, the results presented here suggest that in yeast there exists a tight regulation of TFC6
expression that maintains its protein product as a limiting component of the TFIIIC complex. This
fact raises the question as to why do yeast need to maintain such a stringent control of Tfc6p
expression, and therefore TFIIIC activity. Since we observe that overexpression of Tfc6p
differentially increases the Tfc1p ChIP signal at several loci (Figure 3.10), we speculate that
altered Tfc6p levels might differentially regulate TFIIIC occupancy genome-wide, and possibly
differentially affect expression levels of tRNAs and other Pol III transcripts. Recent studies have
shown that slowly translated rare/sub-optimum codons play a role in fine-tuning translational
regulation and protein stability and activity (Crombie, Boyle et al. 1994; Zalucki and Jennings
2007; Zhang, Hubalewska et al. 2009; Tuller, Carmi et al. 2010; Zhang, Saha et al. 2010),
therefore altered Tfc6p levels might differentially affect the production of tRNAs decoding these
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regulatory codons, potentially having global effects on translational regulation. Although we
have not yet detected any differences in Pol III transcription upon overexpression of Tfc6p (from
a limited set of Pol III transcribed genes tested), a genome-wide analysis may reveal particular
tDNAs whose expression is altered. Since many tDNAs are present in multiple copies in the
yeast genome, such differences may only be revealed by tagging of individual loci to distinguish
altered expression levels.
The work presented here is significant in that it appears to be the first demonstration of a
core Pol III transcription factor that can directly regulate transcription from a Pol II promoter,
that this stringent regulation could potentially be important in global gene expression, and adds
another potential avenue of crosstalk among the different RNA polymerase systems (Conesa,
Ruotolo et al. 2005). Additionally, since ETC-like sites have now been confirmed in human cells,
the role of the TFIIIC complex in genome organization and global control of gene expression may
be more prevalent than previously realized.
Table 3.3. Strains of S. cerevisiae used in this study:
Strain

Genotype

Created

DDY3
DDY232
DDY237
DDY246
DDY247
DDY261
DDY269
DDY416
DDY420
DDY844
DDY3453
DDY4107
DDY4274
DDY4297
DDY4300
DDY4304
DDY4306
DDY4309
DDY4312
DDY4077
DDY4376
DDY4381

MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1
MATα ADE2 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 rpc31-236 hmrΔ
MATα ADE2 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 tfc3-G349E hmrΔ
MATα ade2-1 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 rpc160-Δ1::HIS3 p-rpc160-112
MATa ade2-1 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 rpc160-Δ1::HIS3 p-rpc160-112
MATα ADE2 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 tfc3-G349E hmrΔΙ
MATα ADE2 his-3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 rpc31-236 hmrΔΙ
MATa ADE2 his-3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 brf1Δ::HIS3 p-brf1 II.9 hmrΔ
MATα ADE2 his-3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 brf1Δ::HIS3 p-brf1 II.6 hmrΔ
MATα ADE2 his4-519 leu2-3,112 LYS2 trp1-1 ura3-52 BRF1-3XFLAG-KanMX
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 etc6Δ::URA3
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 TFC6:3XFLAG:KanMX
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #1
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #2
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #3
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #4
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #5
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #6
MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #7
MATa ADE2 his3-11 leu2-3, 112 LYS2 trp1-1 ura3-1 etc6 boxB TFC1-3XFLAG::KanMX
MATa ADE2 his3-11 leu2-3, 112 lys2Δ trp1-1 ura3-1 tfc3-G349E TFC1-3XFLAG::KanMX
MATα ADE2 his3-11 leu2-3, 112 lys2Δ trp1-1 ura3-1 TFC1-3XFLAG::KanMX

(Table 3.3 Continued)
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Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
Donze Lab
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study

DDY4403
DDY4520
DDY4521

MATα/MATa ADE2/ADE2 his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met15Δ0/MET15 TRP1/TRP1
ura3Δ0/ura3Δ0 TFC6/tfc6Δ::URA3
MATα/MATa ade2-1/ADE2 his3-11/his3-11 leu2-3,112/leu2-3, 112 LYS2/lys2Δ trp1-1/trp1-1
ura3-1/ura3-1 TFC6/tfc6Δ::URA3
MATα/MATa ade2-1/ADE2 his3-11/his3-11 leu2-3,112/leu2-3, 112 LYS2/lys2Δ trp1-1/trp1-1
ura3-1/ura3-1 TFC6/etc6 b-box-tfc6Δ::URA3

This Study
This Study
This Study

All strains are isogenic to S. cerevisiae W-303 except for DDY4403, which is in the S288C background (BY4743 parent).
Most experiments were confirmed with at least three independent isolates, only those isolates depicted in the figures are
listed. Strains 4403, 4520, and 4521 contain the URA3 open reading frame expressed from the TFC6 promoter as described
in the text and methods.
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CHAPTER FOUR
DISCUSSION
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Knowledge of the regulation of eukaryotic gene expression is expanding exponentially with
the advent of genomic sequencing, particularly in Saccharomyces cerevisiae, the first eukaryotic
organism in which the entire genomic sequence has been determined (Goffeau, Barrell et al.
1996). Now a vast amount of genomic data is available for the approximately 6000 open reading
frames in this simple budding yeast (Oliver 1996). A large body of research has focused on the
three different eukaryotic RNA polymerases, the different types of promoters they utilize, and
the additional regulatory genomic elements involved in transcriptional regulation. These studies
include the effects on transcription by chromatin domains, along with their associated ciselements and trans-factors.
The cellular processes of transcription, replication, recombination, and repair all have to
occur within the environment of chromatin and the particular hetero- or euchromatic state of the
underlying domain. Regions of these different states of chromatin domains not only influence the
topological characteristics of chromatin, but also the numerous mechanisms of activation and
repression of certain genes at particular points in the cell cycle and developmental stages during
metazoan development. A simple example of a well-studied mechanism of cellular
differentiation (or cell fate) is the haploid mating type stability in S. cerevisiae where the cell
mating type, a or α, is dependent on the silencing of the cryptic mating loci, HMR and HML.
Loss of silencing at these HM loci can result in the cell taking on the characteristics of a nonmating diploid.
Eukaryotic genomes are typically organized into domains containing individual genes or
gene clusters that have distinct patterns of expression. Boundary elements, consisting of barriers
and insulators, are specific sequences in the genome along with their associated DNA-binding
proteins that inhibit the spread of heterochromatin into transcriptionally active euchromatic

101

regions and block the ectopic activation of genes from distal enhancers, respectively. Both
elements are critical for the proper transcriptomal expression of the eukaryotic genome. Studying
these elements in yeast enables us to acquire information on how the genome is organized and
how the cell takes on a certain characteristic that differentiates it from another cell. This
dissertation has focused on the study of the functional mechanisms of boundary elements,
barriers and insulators, in their natural context.
Two main models have been proposed to explain how silenced domains are restricted from
spreading by barrier elements. The nuclear organization model posits that barrier elements tether
chromatin to nuclear superstructures to form topologically distinct domains, and this tethering
prevents the spread of silenced chromatin. The chromatin modifying model suggests that barrier
elements utilize chromatin modifying activities, which modify the underlying chromatin
structure, making it less amenable for the spread of silenced chromatin. There are two variations
of the chromatin modifying model. One variation suggests that silenced chromatin is restricted
from spreading simply as a result of the competition between chromatin-opening and condensing factors at the boundary. Silencing is restricted from spreading by this mechanism at
some native yeast telomeres (Kimura and Horikoshi 2004). The other variation suggests that the
binding of sequence-specific factors (e.g. TFIIIC at the A and B box; TATA-like sequences for
Pol III machinery components) to the barrier element creates a nucleosome-free region, and this
nucleosome-free gap at the boundary is sufficient to block the spread of heterochromatic proteins
(Bi, Yu et al. 2004).
The transcriptional potential of the tDNA barrier at HMR and the assembly of the RNA
polymerase III transcription complex is shown to be critical for barrier function, as mutations in
the tDNA promoter reduce barrier activity (Donze, Adams et al. 1999; Donze and Kamakaka
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2001). Mutations in the genes for the RNA polymerase III transcription factors Brf1p or Tfc3p,
or the HMR-tRNA gene itself prevents binding of these factors and thus weakens the boundary
function (Donze and Kamakaka 2001). Nhp6a and Nhp6b, which have a demonstrated role in
Pol III transcription of the SNR6 (U6 RNA) gene and a subset of tDNAs, are also implicated in
the barrier function of the HMR-tRNA as deletion of both genes substantially weakens the ability
of the HMR-tRNA gene to block the propagation of Sir protein mediated silencing (Braglia,
Dugas et al. 2007).
The deacetylase action of Sir2p has a preference for lysines 9 and 14 of H3 and K16 of H4
in vitro (Imai, Armstrong et al. 2000; Tanny and Moazed 2001), whereas in vivo all acetylatable
lysines of histones H3 and H4 are fully deacetylated at silenced loci (Suka, Suka et al. 2001).
Enhanced silencing in an rpd3Δ background cannot be accounted for by increased expression of
SIR genes since the only Sir protein required at all three silent loci in yeast, Sir2p, weakens
silencing at the HM loci when SIR2 is overexpressed (Fritze, Verschueren et al. 1997; Smith,
Brachmann et al. 1998). Overexpressing SIR4 also has the same effect of weakening silencing at
all three silent loci (Sussel and Shore 1991; Renauld, Aparicio et al. 1993; Smith, Brachmann et
al. 1998). The same situation would presumably apply to Sir1p. Unlike the initiation of silencing
at the HM loci, SIR1 is not required for silencing at telomeres (Rine and Herskowitz 1987;
Aparicio, Billington et al. 1991) and all but two telomeres, III-R and IV-L, are associated with
silenced chromatin (Pryde and Louis 1999; Lieb, Liu et al. 2001).
The enhanced silencing effect at HMR in an rpd3Δ strain has mechanistically eluded
researchers for nearly fifteen years, but recent research has implicated a redistribution of Sir
proteins across the yeast genome based on global histone N-terminal modifications (SantosRosa, Bannister et al. 2004; Venkatasubrahmanyam, Hwang et al. 2007; Zhou, Zhou et al. 2009).

103

In the early days of rpd3Δ silencing research, three separate hypotheses were proposed to explain
the rpd3Δ effect on enhanced silencing (De Rubertis, Kadosh et al. 1996; Vannier, Balderes et al.
1996; Rundlett, Carmen et al. 1998). The first was based on an indirect effect of increased
expression of a critical, dosage-dependent silencing factor. This was highly unlikely because as
mentioned earlier, it has been shown that increased SIR2 and/or SIR4 expression does not
increase silencing at the HM loci but actually reduces it (Sussel and Shore 1991; Renauld,
Aparicio et al. 1993; Fritze, Verschueren et al. 1997; Cockell, Gotta et al. 1998; Smith,
Brachmann et al. 1998). The second hypothesis stated that the loss of Rpd3p function causes an
increase in the acetylation of the H4 N-terminal lysine residue 12 which correlates with increased
silencing, and because it was determined by ChIP to be specifically acetylated in the chromatin
of the silent HM loci compared to the expressed MAT locus (Braunstein, Sobel et al. 1996).
Recent evidence using a more specific antibody for the lysine 12 modification contradicts this
notion of a hyperacetylation state correlating with silencing (Suka, Suka et al. 2001). The third
hypothesis states that the activity of an unidentified silencing factor is modulated by acetylation
on internal lysine residues. Loss of deacetylase activity would then hyperactivate the silencing
factor leading to stronger silencing.
In its role as a histone deacetylase, Rpd3p does not necessarily participate in „global
deacetylation‟ since the specificity is for histone proteins mainly at targeted gene promoters. The
Rpd3 complex may bind directly and in a sequence-independent manner to histones or histonebinding proteins for the subsequent „global deacetylation‟ of histones. Rpd3p is recruited to
specific sites in the genome via interactions with multiple transcription factors, including Ume6p
(Kadosh and Struhl 1997; Rundlett, Carmen et al. 1998) and the heterodimeric transcription
factor Swi4/Swi6 (Robert, Pokholok et al. 2004). Initial studies on Rpd3p focused on its role in
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the regulation of sporulation-specific genes through Ume6p, and then further studies revealed
that Rpd3p regulates additional cellular functions. A set of genes occupied by Rpd3p encodes
important cell cycle regulators including cyclins and cyclin-dependent kinases. This may
explain, in part, the importance of Rpd3p in meiosis (Vannier, Balderes et al. 1996). Rpd3p and
Sin3p occupy a total of approximately 100 genes (p<0.005) and, given that each is a component
of the larger Rpd3(L) complex, are essentially associated with the same genes (Kurdistani, Robyr
et al. 2002).
Through our genetic screen of UV-mutated rpd3Δ strains, we identified two genes, BRE1
and BRE2, which are involved in the enhanced silencing effect of rpd3Δ at HMR and have a
tremendous influence on global histone methylation. Our results also give the indication that
regulation of both euchromatic and heterochromatic environments are more complex than
previously thought. We are given clues as to the occurrence of possible indirect effects of both
chromatin-binding and chromatin-influencing proteins on genomic environments along with the
fact that the covalent modifications on the N-terminal tails of histone proteins are in a constant
state of flux. The assayed cells only reflect a particular state at a particular moment in time of the
underlying chromatin, but this constant state of flux can still allow certain histone modifications
to serve as epigenetic marks for chromatin states.
The histone H3/H4 tetramer would be the likely candidate to serve as a location for
epigenetic marks, since the passage of the replication fork causes the two H2A-H2B dimers to
disassociate from both the H3-H4 tetramer and the DNA. The H3-H4 tetramers remain
associated with DNA (Kimura and Cook 2001) and are randomly distributed to the sister
molecules during replication (Jackson and Chalkley 1985). In the inheritance of the
heterochromatic state (silenced regions), the H3-H4 tetramers disassociated from H2A-H2B
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would be hypoacetylated and Sir proteins may remain associated with the H3 and H4 histone
tails after the passage of the replication fork. Newly synthesized acetylated histones could be
adjacent to old H3-and H4-bound Sir2p which would influence the deacetylation of the adjacent
nucleosomes creating high affinity binding sites for Sir3p and Sir4p and thus the reestablishment of silencing. The use of certain histone modifications as epigenetic marks is
critical in S. cerevisiae, since there is no utilization of DNA modifications (i.e. CpG
methylation). A new paradigm is beginning to emerge that the deacetylation of histones H3/H4 is
not the only potential epigenetic mark to maintain silencing. This stands to be true as new
evidence brings a higher complexity to histone modification states. Although core histones are
among the most conserved proteins known in all organisms, they are also among the most
diverse regarding posttranslational modifications.
Transcript levels of the two NAD+ biosynthesis genes detected in our genetic screen, QNS1
and NPT1, were not significantly modulated between our WT and rpd3Δ strains. Studies have
shown that only telomeric and rDNA silencing in S. cerevisiae are dependent on the nuclear
NAD+ salvage pathway (Llorente and Dujon 2000) and mutations in the SIR2 gene itself does
not significantly affect overall intracellular NAD+ concentration (Sandmeier, Celic et al. 2002).
Another Sir2 family member of HDACs (class III NAD+-dependent), Hst2p, is actually
responsible for most of the NAD+-dependent deacetylase activity from whole cell extracts
(Smith, Brachmann et al. 2000). It is interesting to note that the NAD+-dependent glutamate
dehydrogenase, GDH2, was identified in our genetic screen. Since GDH2 requires the cofactor
NAD+ for its enzymatic activity of converting glutamate to α-ketoglutarate, it seems implausible
that GDH2 would be an effector, since the requirements of Gdh2p would sequester the NAD+
cofactor, thus inhibiting the availability of NAD+ to Sir2p and its effects on extended silencing at
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HMR. Although GDH2 was not verified as a potential effector upon gene knockout, this scenario
is still highly unlikely due to the numerous pathways for NAD+ to replenish in the cell. It may
take changes in some or all of the NAD+ pathway genes to observe a significant change in NAD+
concentration that would negatively affect Sir protein-mediated silencing at HMR. Topologically,
it would be very efficient for the cell to replenish the nicotinamide by-product of the Sir2p
deacetylase reaction back into NAD+ near the sites of silencing. This would ensure a constant
supply of NAD+ for Sir2p in the nucleus.
Rad6p is involved in the ubiquitylation of histones H2A, H2B, and H3 in vitro (Sung,
Prakash et al. 1988; Haas, Reback et al. 1990) which suggests a role for Rad6p as a modifier of
localized chromatin structure (Picologlou, Brown et al. 1990; Kang, Yadao et al. 1992; Liebman
and Newnam 1993). Early studies implicated Rad6-mediated ubiquitylation as a regulator of
silencing in both S. cerevisiae and S. pombe (Bryk, Banerjee et al. 1997; Huang, Kahana et al.
1997; Singh, Goel et al. 1998). Histone H2B is ubiquitylated by Rad6p at lysine residue 123
through its association with the E3 ubiquitin ligase, Bre1p (Robzyk, Recht et al. 2000) which
was an identified effector in our genetic screen. It has been previously shown that mutation of
RAD6 or histone H2BK123 completely abolishes H3K4 methylation by Set1p, which illustrates
the trans-histone dependence of this chromatin modification (Sun and Allis 2002). Rad6p is also
involved in many cellular processes including DNA repair, UV-induced mutagenesis, N-end rule
protein degradation, sporulation, and Ty1 integration specificity (Picologlou, Brown et al. 1990;
Kang, Yadao et al. 1992; Liebman and Newnam 1993; Prakash, Sung et al. 1993). From our
results, and because Rad6p is associated with BRE1, there could be a mechanistic association
with rpd3Δ extended silencing. Could the mechanism be that silencing is dependent upon the
ubiquitylation of a silencing regulator? One posed explanation is that Rpd3p regulates expression
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of RAD6 which in turn is required for silencing, but it has been shown that Rad6p protein levels
are unchanged between WT and rpd3Δ strains (Sun and Allis 2002).
The Bur1/Bur2 cyclin dependent protein kinase is required for histone H2B
monoubiquitylation by Rad6/Bre1. Negative effects on histone monoubiquitylation and
methylation can be the result of defective Bur1/Bur2-mediated phosphorylation of Rad6p on its
serine residue 120 resulting in inhibited recruitment of the Paf1 complex, a Pol II elongation
factor, to chromatin. Serine 120 of Rad6p has been shown to be required for silencing of
telomere-associated genes, and the overall regulation of gene expression in vivo (Wood,
Schneider et al. 2005). Mutation of Rad6p serine 120 to alanine leads to a loss of telomeric
silencing comparable to that seen in mutants deleted for RAD6, BRE1, or RTF1, all of which are
required for histone H2B monoubiquitylation and histone H3 methylation by COMPASS and
Dot1p (Wood, Krogan et al. 2003).
COMPASS is a histone H3 lysine 4 (H3K4) methylase consisting of Set1p (KMT2) and
seven other polypeptides, including Swd2p, the only essential subunit. H3K4 is methylated by
the Set1p methyltransferase during transcriptional elongation, through association with the Ser5phosphorylated CTD of RNA polymerase II (Ng, Robert et al. 2003). The mechanism by which
the Set1p methyltransferase of COMPASS differentially methylates H3 (mono-, di-, and tri-) is
still not understood. Also, the molecular mechanisms for the histone crosstalk between histone
H2B monoubiquitylation by Rad6/Bre1 and the H3K4 trimethylation by COMPASS are poorly
understood. In the absence of H2B monoubiquitylation, H3K4 monomethylation is present,
however, H3K4 di- and trimethylation are not detectable (Schneider, Wood et al. 2005;
Shahbazian,

Zhang

et

al.

2005).

COMPASS

purified

from

strains

lacking H2B

monoubiquitylation is incapable of di- and trimethylating histone H3K4 and has reduced levels
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of the COMPASS subunit Swd2p. Some findings offer insight into the molecular role of Swd2p
in translating the H2B monoubiquitination signal into H3 methylation (Figure 4.1). The Swd2p
recruitment to chromatin via H2B monoubiquitination can bring this subunit in close proximity
to COMPASS (interacting with Pol II through the Paf1 complex), resulting in their physical
interactions, and therefore, H3K4 di- and trimethylation.

Adapted from Lee et al. Cell, Vol. 131, 2007, p1092.
Figure 4.1. Swd2p is required for translating histone crosstalk between H2B
monoubiquitylation and H3 methylation by COMPASS. COMPASS interacts with the
elongating form of Pol II via its interaction with Paf1 complex. A) In the absence of H2BK123
monoubiquitylation by Rad6/Bre1, COMPASS can still interact with Pol II via the Paf1 complex
and monomethylate H3K4. B) Through H2BK123 ubiquitylation, Swd2p is recruited to
chromatin either directly or indirectly in a COMPASS independent manner. According to this
model, the association of Swd2p with COMPASS can facilitate H3K4me3 through its
association with another unspecified interaction between Swd2p and the monoubiquitylation of
H2BK123. Through this mechanism dependent on ubiquitylation of H2BK123, Swd2p would
also associate with Dot1p for the tri-methylation of H3K79.

109

In a paf1Δ mutant, both H3K4me2 and H3K4me3 are eliminated, but H3K4me1 is not
affected. Set1p can catalyze H3K4me1 independent of PAF1, thus independent of Pol II
elongation, but conversion to H3K4me2 or -me3 requires PAF1 and association with Pol II. The
association of Swd2p in a monoubiquitination-dependent manner can result in some
posttranslational modification(s) of Swd2p which could facilitate the interaction of Swd2p with
COMPASS (Lee, Shukla et al. 2007).
The proposed mechanism above is attractive since it explains how both BRE1 and BRE2 are
participating in the methylation status of both H3K4 and H3K79. Particularly, it shows how
BRE1 is required for the trimethylation of H3K4 and H3K79, but it also indicates how BRE2 is
directly involved in the monomethylation of H3K4 and how there is a potentially allosteric
involvement (through its association with COMPASS) in the enzymatic requirements of the
trimethylation of H3K4; plus how this potential allosteric involvement through the association
with Swd2p indirectly effects methylation of H3K79. Since both BRE1 and BRE2 are effectors
of the rpd3Δ silencing effect identified in our results, it stands to reason that only the
trimethylation status of H3K4 exerts its effects on Sir protein-mediated silencing, but the
influence of H3K79 methylation may be far more reaching than previously thought. The question
that remains is how the trimethylation of H3K4 and/or H3K79 is involved in the extended
silencing effect of rpd3Δ at HMR.
An interesting and plausible hypothesis for BRE1‟s influence on rpd3Δ enhanced silencing
comes through the interaction of NAT1-acetylated Sir3p with methylated H3K79. It has been
shown that the binding of Sir3p to histone peptides in vitro is negatively affected by the
methylation and acetylation of the tails of histone H3 and H4 (Carmen, Milne et al. 2002;
Santos-Rosa, Bannister et al. 2004; Liou, Tanny et al. 2005). Binding of Sir3p to histone tails
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throughout the genome is mediated by the C-terminus of Sir3p (Gasser and Cockell 2001). The
C-terminus of Sir3p contains a BAH domain that binds to histone H3K79. Importantly,
acetylation of the BAH domain is required for the binding specificity of Sir3p for nucleosomes
unmethylated at H3K79 (van Welsem, Frederiks et al. 2008) (Figure 4.2).

Adapted from van Welsem et al. Mol. Cell Bio, Vol. 28 No.11, 2008, p.3869.
Figure 4.2. Model for the interaction between Dot1p and the acetylated N-terminus of Sir3p
in silencing. Sir1 recruits the Sir 2/3/4 complex in cis to the E silencer at HMRa. Dot1p acts by
methylation (me) of histone H3K79 in euchromatic regions which prevents promiscuous binding
of Sir proteins, thus concentrating the Sir proteins at HMRa in trans. The N-terminus of the BAH
domain of Sir3p interacts with the core domain of the nucleosome encompassing H3K79,
whereby the acetylated Sir3p is able to discriminate between methylated and unmethylated
H3K79 and preferably binds to unmethylated H3K79. In the absence of acetylated Sir3p, Sir3p
loses its specificity for unmethylated H3K79 and binds to euchromatic regions thus diluting Sir
protein concentration at HMRa.
With the deletion of Dot1p, binding of Sir2p and Sir3p at silent chromatin is reduced, and
Sir3p becomes redistributed (San-Segundo and Roeder 2000; Ng, Feng et al. 2002; van
Leeuwen, Gafken et al. 2002; Ng, Robert et al. 2003) which can reduce silencing at HMR. This
same scenario can apply to the deletion of BRE1 since Dot1p trimethylation at H3K79 is
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dependent on the ubiquitylation of H2BK123 mediated by Rad6/Bre1 (Figure 4.1). Some genetic
evidence is consistent with this model in which the N-terminus of the BAH domain of Sir3p
binds histone H3K79 on the nucleosome core. Specific point mutations in the Sir3p N-terminus,
the deletion of NAT1 (N-terminal acetyltransferase), and the deletion of DOT1 each had very
similar silencing phenotypes that showed reduced telomeric silencing (van Welsem, Frederiks et
al. 2008). It would be interesting to see if a decrease in extended silencing occurs at HMR upon
deletion of NAT1 in the rpd3Δ background.
Based on results by van Welsem et al. (2008), the Sir3p N-terminus binds the nucleosome
core on a surface that includes histone H3K79 and acetylation of the Sir3 N-terminal alanine is
required for the specificity of Sir3p for unmethylated histone H3K79. In the absence of this
specificity (mutant or unacetylated Sir3p or no histone H3K79me in euchromatin), Sir3p
becomes a promiscuous chromatin-binding factor, which leads to reduced Sir3p binding in silent
regions, since Sir3p is in limited supply (van Welsem, Frederiks et al. 2008) (Figure 4.2).
Biochemical studies (Onishi, Liou et al. 2007) demonstrate the binding of the Sir3p BAH domain
to yeast nucleosomes is negatively affected by H3K79me, although it is not clear whether these
interactions also occur with nucleosomes in vivo (van Welsem, Frederiks et al. 2008).
Sir2p has been shown to be mainly localized to two distinct sub-nuclear domains, telomeres
and the nucleolus (Gotta, Strahl-Bolsinger et al. 1997). The nucleolus has been proposed to serve
as a reservoir for Sir2p storage, competing with subtelomeric regions and HM loci for a limiting
supply of Sir2p (Maillet, Boscheron et al. 1996; Gotta, Strahl-Bolsinger et al. 1997; Smith,
Brachmann et al. 1998). A global redistribution of a limited pool of Sir2–4 to euchromatin would
be expected to result in weak silencing at euchromatic loci, thus the depletion of Sir proteins
from heterochromatic regions resulting in dramatically reduced silencing. The fact that Sir3p is
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undetectable at euchromatic loci by ChIP suggests that, compared with Sir protein association at
sites near and within the silenced loci, ectopic Sir binding is much weaker and/or transient and
occurs at a given gene only in a fraction of all cells (Venkatasubrahmanyam, Hwang et al. 2007).
In accordance with the view that Sir proteins can be redistributed in the nucleus,
immunolocalization studies of Sir2p showed that in H4K5Q rpd3Δ cells, most of the Sir2p signal
was congregated in the nucleolus instead of diffused throughout the nucleus as was observed in
rpd3Δ cells with wild-type histone proteins. These observations indicate that deacetylation of
H4K5 by Rpd3p is likely required for restricting the spread of Sir2p into euchromatic regions
and is important for limiting heterochromatic silencing. Considering that H4K5 is one of the
targets of Rpd3p, it has been postulated that boundary formation in the subtelomeric and HMR
regions requires H4K5 deacetylation (Zhou, Zhou et al. 2009); again however, it is
counterintuitive to rationalize how an increase in H4 acetylation would be important for the
propagation of heterochromatin. When Rpd3p is absent, could an increase of H4K5 acetylation
facilitate Sir2p binding? The mechanism as to how the increase of H4 acetylation caused by
Rpd3p inactivation facilitates the establishment of silent chromatin remains mysterious, and
requires further investigation.
The deacetylation reaction of Sir2p is distinct from that of non NAD+-dependent HDACs in
that it not only produces nicotinamide as a by-product, but also an unusual compound, O-acetylADP ribose (OAADPR) (Tanner, Landry et al. 2000), which has been proposed to influence SIR
complex stability (Liou, Tanny et al. 2005). Another proposed mechanism based on recent
evidence suggests histone deacetylation by Rpd3p removes the substrate for Sir2p (H4K16), so
that Sir2p no longer can produce O-acetyl-ADP ribose (OAADPR) by consumption of NAD+ in
the deacetylation reaction. In this model, OAADPR therefore is unavailable for binding to Sir3p,
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preventing SIR complex propagation (Ehrentraut, Weber et al. 2010). Intriguingly, the Sir3
protein carries a domain that resembles the ATP binding pocket of AAA+ ATPases but lacks
certain catalytic residues (Neuwald, Aravind et al. 1999). It therefore has been hypothesized that
this domain constitutes an OAADPR binding site (Gasser and Cockell 2001). Therefore,
heterochromatin spreading is stopped by the inability of Sir2p to perform histone deacetylation,
to produce OAADPR, and thus to support heterochromatin spreading.
In light of recent evidence, the loss of silencing at HMR that was observed in our double
mutants, bre1Δrpd3Δ and bre2Δrpd3Δ, could be the result of the loss of H3K4me3 and
H3K79me3 genome-wide, which would promote the promiscuous binding of Sir proteins into
euchromatic regions, thus diluting them from areas of typical heterochromatic dominance.

Figure 4.3. Model of the re-distribution of Sir proteins in wild-type vs. rpd3Δ cells. Normal
silencing at HMR occurs due to adequate concentration of Sir proteins at this region with limited
promiscuous binding of Sir proteins in euchromatic regions in wild-type cells. The loss of the
deacetylase Rpd3p results in a loss of global deacetylation and fewer deacetylated histone targets
in euchromatic regions. The limited pool of Sir proteins would concentrate higher at the normal
silenced region of HMR resulting in an increase of extended silencing enough to bypass the tRNA
barrier and silence the downstream ADE2 gene
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How does this relate to the global loss of deacetylation in an rpd3Δ strain? Since our study
mainly focuses on elucidating the mechanism of extended silencing at HMR, we posit a model
where in wild-type cells, the limiting pool of Sir proteins are concentrated enough at HMR to
repress the transcription of the a-specific mating type genes, but not concentrated enough to
bypass the tRNA barrier element and silence the downstream ADE2 gene (Figure 4.3).
In this model, a fraction of the silencing proteins are distributed to other chromosomal
regions near euchromatic regions where deacetylated nucleosomes are always potential targets of
transient or limited binding of Sir proteins. In rpd3Δ strains, the global loss of deacetylation
causes a subsequent increase in the global acetylation of nucleosomes, which would inhibit the
binding of Sir proteins to euchromatic regions. The distribution of this freed pool of Sir proteins
would shift to heterochromatic regions such as HMR, which could override the tRNA barrier
element and silence the ADE2 marker gene. So, is the increasing silencing effect of rpd3Δ due to
a global re-distribution of Sir proteins based on the acetylation status of euchromatic regions?
DamID (DNA adenine methyltransferase) methodology, first established in Drosophila
melanogaster, is a method used to profile chromatin-associated proteins (van Steensel and
Henikoff 2000). Studies using the fusion of Sir3p and Sir4p to Escherichia coli Dam in wild-type
and set1Δhtz1Δ strains resulted in Dam-mediated DNA methylation at sites where Sir3p or Sir4p
was bound to chromatin. With no endogenous DNA methylation in S. cerevisiae, the percentage
of cells methylated at a particular locus provided a read-out of the chromatin association of Sir3p
or Sir4p (Venkatasubrahmanyam, Hwang et al. 2007). Sir-dam fusion proteins result in
methylated GATC sites at Sir protein bound sites in the genome, and can be digested by the
restriction endonuclease DpnI. Oligo primer sets targeted at specific genomic locations can
reveal the presence or absence of site-specific methylation depending on whether that region has
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been cut by DpnI (no amplification) or not (amplification). Thus, regions in the genome that
have been occupied by either Sir3p or Sir4p can be assessed by reduced amplification using
PCR.

Figure 4.4. Strategy for the genome-wide assessment of Sir proteins using Sir3- or Sir4-dam
methylase fusion proteins. By utilizing Sir3p or Sir4p fused to the E. coli dam methylase, which
contains functionally reduced methylase activity due to conditional mutations in the DNA
binding domain of the enzyme, we can assess the degree of transient Sir protein occupancy in
euchromatic regions and in higher affinity binding heterochromatic regions by the degree of
DNA methylated at GATC sequences. Methylation-specific restriction endonucleases along with
oligo primer sets probing targeted genomic loci can assess limited Sir protein binding.
Currently, our experimentation involves creating both Sir3p and Sir4p functional proteins fused
to an E. coli dam methylase (Figure 4.4). Dam methylase of E. coli catalyzes the transfer of a
methyl group from S-adenosyl-methionine (AdoMet) to the N6 amino group of the adenine in
the sequence GATC (Hattman, Brooks et al. 1978; Geier and Modrich 1979). Our initial
restriction assays using unfused wild-type dam methylase (Sir4pr-dam) showed high global
DNA methylation across the entire genome. This high background made it difficult to distinguish
targeted from untargeted Dam methylation. To attempt to refine the assay, we reasoned that
creating catalytic mutants in the Dam methylase might improve the signal-to-noise ratio at Sir
targeted sites. Based on previous studies of Dam methylase activity, we created three mutations,
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P134S which contains a specific methylase activity of 66% of wild type Dam, G136A (42%),
and R137L (6%) (Guyot, Grassi et al. 1993). Future studies will use unfused dam methylase
mutants driven by the Sir4 promoter region for normalization of this assay. The inherent
extended silencing effect of rpd3Δ at HMR shows that barrier elements such as the tRNAthr gene
can be overcome by Sir protein-mediated silencing when various chromatin processes are
perturbed. As each new piece of evidence contributes to the puzzle, we are progressively getting
a better understanding of the true complexity of barriers in the context of an extremely dynamic
genome.
Like previous studies in our lab, our latest study (autoregulation of TFC6 by TFIIIC in the
TFC6 promoter) is solidifying the role of TFIIIC binding sites as genomic elements with extratranscriptional functions. Our results implicate the B box sequence element of type II RNA
polymerase III (tRNA) genes and ETC sites in insulator function. The question remains if other
ETC sites in budding yeast to humans carry the same regulatory capacity in blocking targeted
activation between genomic domains. It is interesting to speculate how these B box elements
might have been evolutionarily selected to function in an insulator capacity.
The yeast genome contains 274 unclustered tRNA genes which are dispersed throughout its
genome of 16 chromosomes (32 in diploid strains) (Percudani, Pavesi et al. 1997; Hani and
Feldmann 1998). tDNAs are represented as gene sets which redundantly code for 42 tRNA
species with different codon specificities. Individual tRNA species range in copy number from 1
to 16 and correlates with both the frequency of codon occurrence on mRNAs and the
intracellular amount of individual tRNAs (Percudani, Pavesi et al. 1997). Because of tDNA
redundancy, and the intragenic location of the A and B blocks, genes coding for the same tRNA
species in eukaryotes generally share identical TFIIIC-binding promoter elements, but are flanked
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by divergent TFIIIB interacting sequences (Hani and Feldmann 1998). Can varying the nuclear
concentration of TFIIIC differentially control the transcriptional outputs of the various tRNA
gene families? Our results have indicated that overexpression of the TF IIIC component TFC6
increases relative TFIIIC binding at representative tDNA and ETC loci (Figure 3.10). With excess
TFIIIC present, transcriptional output would be proportional to the tRNA gene copy number, but
with limiting TFIIIC the output would be determined by TFIIIC binding affinity to these loci. It is
intriguing to speculate that the cell might exploit varying TFIIIC binding constants based on
Tfc6p levels in the cell to differentially regulate the transcriptional outputs of its various tRNA
gene families.
The origin of isolated B box sequences dispersed throughout the yeast genome, which are
overrepresented between divergently transcribed Pol II genes, remains an interesting
evolutionary notion about the multi-functionality of tRNA genes that are progressively being
discovered. Are ETC loci remnants of early tRNA genes, but have lost A box sequences and
functional TATA-like sequences just upstream of the RNA initiation site since these upstream
sequences heavily influence Pol III transcription in vivo and in vitro by facilitating the
association of TFIIIB? However, many Pol III promoters lack canonical TATA elements and the
transcriptional effects of the TATA-like sequences are quantitatively modest. Do the ETC loci
have DNA sequences that result in positioned nucleosomes that do not interfere with TFIIIC
binding, but essentially block the association of TFIIIB and Pol III? Are DNA-binding proteins
bound at critical positions at the ETC loci blocking the association or recruitment of TFIIIB and
Pol III while not affecting association of TFIIIC? Is TFIIIC bound at the ETC loci in a
conformation that precludes its association with TFIIIB?
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From an evolutionary perspective, the ETC loci may be false Pol III promoters that were
derived from vestigial Pol III genes or could be just fortuitous occurrences of TFIIIC recognition
sequences. The highly conserved promoter sequences between species surely make the former
highly probable. Expanding on this idea, especially in light of the sequence conservation among
related yeast species is that some (and perhaps all) ETC loci are bona-fide Pol III promoters at
which the complete Pol III apparatus assembles only under specific conditions. Perhaps a
modification of TFIIIC or TFIIIB in response to a specific environmental or genetic condition
might permit the recruitment of the intact Pol III machinery to the ETC loci. Alternatively, a
given condition might result in the dissociation of an inhibitory factor that blocks TFIIIB and Pol
III entry at these loci; this could possibly have implications for other mechanisms of regulation
of the neighboring genes. It can be difficult to distinguish between true functional elements and
evolutionary remnants, though the potential to identify new classes of functional elements
always exists. For example, TFIIIC binding sites have the capacity to function as an insulator, as
either a tDNA or an ETC sequence can block the interaction of Gal4p with the GAL10 promoter.
TRT2 tDNA in its natural context serves as an insulator between the STE6 and CBT1 genes,
preventing the STE6 regulatory elements from affecting CBT1 transcription levels (Simms,
Miller et al. 2004).
RNA170 (ETC5) was found as a new, non-essential 170 nucleotide non-coding RNA
transcript (Olivas, Muhlrad et al. 1997; Roberts, Stewart et al. 2003). Following genome-wide
ChIP-CHIP of subunits of Pol III, TFIIIB, and TFIIIC, the low levels of Pol III and TFIIIB that
were present at this locus suggested that RNA170 may be transcribed at very low levels (Roberts,
Stewart et al. 2003). ZOD1 (Zone Of Disparity), which possibly produces short transcripts, is so
named because occupancy by Pol III was initially found to be disproportionately low when
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compared with TFIIIC occupancy (Moqtaderi and Struhl 2004). Nucleosome depletion
dramatically enhances expression of both ZOD1 and ETC5 without affecting their occupancy by
the Pol III machinery (Guffanti, Percudani et al. 2006). The ZOD1 locus is also bound by all
components of the Pol III machinery and was initially implicated as a promoter that is bound by
a transcriptionally incompetent form of the complete Pol III machinery (Stunkel, Kober et al.
1997; Moqtaderi and Struhl 2004). The ZOD1 region is riddled with poly(dT) stretches, which
can act as termination signals for Pol III, so the resulting short RNAs are likely to be quickly
degraded and hence difficult to detect. Although this model might imply that ZOD1 is a
meaningless pseudogene or other genomic relic, the high conservation in yeast of the ZOD1 A
and B blocks, as well as the conserved binding of Pol III factors to this locus suggest that any
localized Pol III transcription may have a physiological function. Comparative genomic analysis
revealed that the ZOD1 promoter is the only surviving portion of a tDNAIle ancestor, whose
transcription capacity has been preserved throughout evolution independently from the encoded
RNA product. Another TFIIIC/TFIIIB-associated element in the S. cerevisiae genome, iYGR033c,
was also identified as a conserved tDNAArg remnant (Guffanti, Percudani et al. 2006).
In S. pombe, inverted repeat (IR) boundary elements flanking the mating-type
heterochromatin domain also contain B-box sequences, which prevent heterochromatin from
spreading into neighboring euchromatic regions by recruiting the TFIIIC complex without Pol III.
The IR elements actually contain multiple B box sequences that are also required for efficient
transcription of IRs by RNA Pol II. This finding resulted in a subsequent genome-wide profiling
analysis which unexpectedly identified a number of COC sites dispersed across the fission yeast
genome. These TFIIIC-bound sequences are tethered to the nuclear periphery in a B box
dependent manner (Noma, Cam et al. 2006). Similar to the IR boundaries, multiple B boxes are
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located at these TFIIIC bound regions. Interestingly, most of these loci were found in intergenic
regions between divergent Pol II genes and one of the divergent Pol II promoter regions
occupied by TFIIIC is the gene SFC3 (TFC6 ortholog in Saccharomyces), suggesting the
potential for transcriptional autoregulation of SFC3 by TFIIIC in fission yeast (Noma, Cam et al.
2006). ETC loci in budding yeast might have a role in genome organization via the tethering of
specific chromosomal regions to subnuclear structures, akin to the clustering of tRNA genes near
the nucleolus (Thompson, Haeusler et al. 2003).
Recent ChIP, followed by massive parallel sequencing (ChIP-Seq), data of Pol III
components puts the human ETC site list at 5,474 loci, in contrast with 1,520 for the RNA Pol III
subunit Rpc155, even though fold enrichments, and hence assay sensitivity, is higher for
Rpc155. In these studies, an ETC locus was defined as having a TFIIIC/Rpc155 ratio higher than
2.04, 3 s.d. above this median ratio. ETCs by this definition do not need to be completely lacking
in Pol III occupancy. Under these strict experimental criteria (only 3 tRNAs passed), 1,865 ETCs
were identified and the distribution of TFIIIC-occupied loci of both ETC and some non-ETC
types revealed a positional bias toward the transcription start sites (TSSs) of Pol II genes. 181
ETC loci with the highest levels of TFIIIC occupancy were strikingly well correlated with the
TSSs of Pol II genes, with 68% being located within 1 kilobase of a Pol II TSS (Moqtaderi,
Wang et al. 2010). This is reminiscent of the S. cerevisiae ETCs, which are ~200–300 bp
upstream of a neighboring Pol II gene. Interestingly, these studies also revealed differences in
TFIIIC occupancy at ETC loci between HeLa S3 and K562 cells suggesting that TF IIIC binding
and/or TFIIIB recruitment at ETC loci is possibly influenced by cell type specific factors
(Moqtaderi, Wang et al. 2010). While the genomic role of ETC sites has not been studied in
depth, our results suggest that TFIIIC binding sites may have general functions as boundary
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elements, and in the specific example of the TFC6 promoter, may function as an autoregulated
insulator (Figure 4.5).

Figure 4.5. TFIIIC potentially functions as an insulator to the targeted activation of the
TFC6 promoter by a putative DNA-binding transcription factor. The binding of the TFIIIC
complex to the ETC6 site is autoregulated by its own protein product and inhibits the targeted
activation and the assembly of a preinitiation complex either through steric hindrance or the
blockage of a tracking mechanism at the TFC6 promoter resulting in lower TFC6 expression.
Directional TF targeting near the TSS of TFC6 has been omitted for clarity.
Relative levels of the Tfc6 protein are lower as compared to other essential TFIIIC subunits
(Ghaemmaghami, Huh et al. 2003; Kleinschmidt, Leblanc et al. 2011), so the auto-regulatory
mechanism at the TFC6 promoter gives credence to Tfc6p as a limited component to TFIIIC
assembly/binding, thus having a potentially tremendous impact on maintaining cellular TFIIIC
levels. Does this affect the overall regulation of tRNA genes? Since our results indicate that the
regulation of TFC6 is dose-dependent on the levels of its own protein product, we also
investigated the global effect of TFC6 overexpression on other Pol III promoter elements such as
tRNA genes and other ETC loci in the yeast genome. Currently, there are no other studies
showing that overexpression of any TFIIIC component causes an increase in either TFIIIC binding
to tRNA genes or ETC sites. Future overexpression studies of TFC6 will mainly focus on the
effects at tRNA genes and the possible effects of regulatory output. ChIP-Seq analysis should
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give us whole-genome data determining which TFIIIC-occupied loci shows higher enrichment
upon overexpression of TFC6. Also, it is technically difficult to measure the transcriptional
activity of individual tRNA genes because most are repeated. Based on ChIP-Seq data, we can
assay any Pol III transcribed gene of interest by tagging the tRNA genes showing higher TFIIIC
binding upon TFC6 overexpression.
The lower levels of TFC6 expression in our promoter mutant #3 also points to a potential
DNA-binding protein that seems to function as a transcriptional activator for TFC6, which could
participate in the assembly of an RNA Pol II initiation complex near the TSS of TFC6. Sequence
analysis of this promoter region shows sequence similarity to the DNA-binding site of Reb1p.
The role of Reb1p, as the putative DNA-binding transcription factor, is currently being assessed
by analyzing the effects of REB1 overexpression on TFC6 promoter activity. If Reb1p is the
putative transcription factor bound to promoter region #3, then overexpressing REB1 should
ultimately show increased rate of growth on media lacking uracil in our TFC6 promoter-URA3
strains described in Chapter 3.
Reb1p is among the abundant so-called “general regulatory factors.” It is a multifunctional
transcription factor encoded by an essential gene. The 125-kDa protein binds as a monomer to its
site on DNA with the consensus YNNYYACCCG, and its DNA-binding domain is homologous
to the vertebrate proto-oncogene myb. Reb1p has an architectural role, and its DNA binding is
necessary and sufficient to keep nucleosomes off the DNA region spanning the core promoter
(Ju, Morrow et al. 1990; Morrow, Ju et al. 1993).
An alternative hypothesis to the role of TFIIIC as an insulator can include another proposed
mechanism of regulation at the TFC6 promoter region. There is the possibility of competitive
binding between the unknown DNA-binding protein and TFIIIC at the short stretch of DNA
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between promoter region #3 and the ETC6 site (Figure 4.6). Since the TFC6 promoter element
(promoter region #3) is immediately upstream of the ETC6 B-box (~12bp), it stands to reason
that TFIIIC when bound might occlude the binding of the transcription factor resulting in
decreased TFC6 expression (Figure 4.6 B). The same situation could occur with the transcription
factor bound at promoter region #3 where the assembly of the entire TFIIIC complex is inhibited
resulting in increased TFC6 expression (Figure 4.6 A).

Figure 4.6. Competition between TFIIIC and transcription factor (TF) for binding the
limited region of putative UAS and ETC6. A) In the competition model of TFC6 transcription
activation, the binding of the putative transcription factor to promoter region #3 occludes the
binding of TFIIIC to the ETC6 site and activates TFC6 transcription. B) Increased levels of
TFIIIC will bind to the ETC6 site and occlude the putative transcription factor from binding at
the promoter region #3 thus lowering TFC6 expression.
It is clearly evident that chromatin boundary elements play an expanding role in the natural
context of eukaryotic genomes. The extra-transcriptional effects of tDNAs (tRNA genes) and the
influence they have on gene regulation and chromatin organization show that eukaryotic
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genomes are not only dependent on the sequence of nucleotides on chromosomes, but are also
epigenetically controlled at all stages of cellular differentiation in the life of all eukaryotic
organisms.
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